Document and Entity Information - USD ($) shares in Millions, $ in Billions	12 Months Ended
	Sep. 29, 2018	Nov. 16, 2018	Mar. 31, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	BERRY GLOBAL GROUP INC
Entity Central Index Key	0001378992
Current Fiscal Year End Date	--09-29
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Ex Transition Period	false
Entity Public Float			$ 7.2
Entity Common Stock, Shares Outstanding		131.2
Document Type	10-K
Amendment Flag	false
Document Period End Date	Sep. 29, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Consolidated Statements of Income [Abstract]
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Costs and expenses:
Cost of goods sold	1,705	1,690	1,596	1,447	1,514	1,518	1,453	1,206	6,438	5,691	5,202
Selling, general and administrative									480	494	531
Amortization of intangibles									154	154	143
Restructuring and impairment charges									36	24	32
Operating income									761	732	581
Other expense (income), net									25	14	(18)
Interest expense, net									259	269	291
Income (loss) before income taxes									477	449	308
Income tax (benefit) expense									(19)	109	72
Net income (loss)	$ 133	$ 110	$ 90	$ 163	$ 110	$ 107	$ 72	$ 51	$ 496	$ 340	$ 236
Net income per share:
Basic (see Note 14) (in dollars per share)	$ 1.01	$ 0.84	$ 0.69	$ 1.24	$ 0.84	$ 0.82	$ 0.56	$ 0.42	$ 3.77	$ 2.66	$ 1.95
Diluted (see Note 14) (in dollars per share)	$ 0.99	$ 0.81	$ 0.66	$ 1.20	$ 0.81	$ 0.79	$ 0.54	$ 0.40	$ 3.67	$ 2.56	$ 1.89

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 496	$ 340	$ 236
Currency translation	(127)	34	(1)
Pension and postretirement benefits	3	38	(23)
Interest rate hedges	49	28	(14)
Provision for income taxes	(13)	(20)	9
Other comprehensive (loss) income, net of tax	(88)	80	(29)
Comprehensive income (loss)	$ 408	$ 420	$ 207

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Current assets:
Cash and cash equivalents	$ 381	$ 306
Accounts receivable, net	941	847
Inventories	887	762
Prepaid expenses and other current assets	76	89
Total current assets	2,285	2,004
Property, plant and equipment, net	2,488	2,366
Goodwill and intangible assets, net	4,284	4,061
Other assets	74	45
Total assets	9,131	8,476
Current liabilities:
Accounts payable	783	638
Accrued expenses and other current liabilities	416	463
Current portion of long-term debt	38	33
Total current liabilities	1,237	1,134
Long-term debt, less current portion	5,806	5,608
Deferred income taxes	365	419
Other long-term liabilities	289	300
Total liabilities	7,697	7,461
Commitments and contingencies
Stockholders' equity:
Common stock (131.4 and 130.9 shares issued, respectively)	1	1
Additional paid-in capital	867	823
Non-controlling interest	3	3
Retained earnings	719	256
Accumulated other comprehensive loss	(156)	(68)
Total stockholders' equity	1,434	1,015
Total liabilities and stockholders' equity	$ 9,131	$ 8,476

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Common Stock [Member]	Additional Paid-in Capital [Member]	Non-Controlling Interest [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings (Deficit) [Member]	Total
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of excess tax benefit from the adoption of ASU 2016-09 \| Accounting Standards Update 2016-09 [Member]	$ 0	$ 0	$ 0	$ 0	$ 36	$ 36
Balance at Sep. 26, 2015	1	406	3	(119)	(356)	(65)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	20	0	0	0	20
Proceeds from issuance of common stock	0	26	0	0	0	26
Interest rate hedge, net of tax	0	0	0	(9)	0	(9)
Net income attributable to the Company	0	0	0	0	236	236
Currency translation	0	0	0	(1)	0	(1)
Defined benefit pension and retiree health benefit plans, net of tax	0	0	0	(19)	0	(19)
Other equity	0	(3)	0	0	0	(3)
Balance at Oct. 01, 2016	1	449	3	(148)	(84)	221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	20	0	0	0	20
Proceeds from issuance of common stock	0	31	0	0	0	31
Interest rate hedge, net of tax	0	0	0	18	0	18
Net income attributable to the Company	0	0	0	0	340	340
Currency translation	0	0	0	34	0	34
Defined benefit pension and retiree health benefit plans, net of tax	0	0	0	28	0	28
Equity issuance, net (see Note 2)	0	323	0	0	0	323
Balance at Sep. 30, 2017	1	823	3	(68)	256	1,015
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	0	23	0	0	0	23
Proceeds from issuance of common stock	0	23	0	0	0	23
Common stock repurchased and retired	0	(2)	0	0	(33)	(35)
Interest rate hedge, net of tax	0	0	0	36	0	36
Net income attributable to the Company	0	0	0	0	496	496
Currency translation	0	0	0	(127)	0	(127)
Defined benefit pension and retiree health benefit plans, net of tax	0	0	0	3	0	3
Balance at Sep. 29, 2018	$ 1	$ 867	$ 3	$ (156)	$ 719	$ 1,434

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Cash Flows from Operating Activities:
Net income	$ 496	$ 340	$ 236
Adjustments to reconcile net cash from operating activities:
Depreciation	384	367	382
Amortization of intangibles	154	154	143
Non-cash interest expense	4	9	9
Share-based compensation expense	23	20	20
Deferred income tax	(86)	5	31
Settlement of interest rate hedge	30	0	0
Other non-cash operating activities, net	16	25	(9)
Changes in operating assets and liabilities:
Accounts receivable, net	(53)	(41)	(34)
Inventories	(79)	10	9
Prepaid expenses and other assets	18	27	21
Accounts payable and other liabilities	97	59	49
Net cash from operating activities	1,004	975	857
Cash Flows from Investing Activities:
Additions to property, plant and equipment	(336)	(269)	(288)
Proceeds from sale of assets	3	6	5
Acquisition of business, net	(702)	(515)	(2,283)
Other investing activities, net	0	4	(13)
Net cash from investing activities	(1,035)	(774)	(2,579)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings	498	495	2,490
Repayment of long-term borrowings	(335)	(636)	(524)
Proceeds from issuance of common stock	23	31	26
Repurchase of common stock	(33)	0	0
Payment of tax receivable agreement	(37)	(111)	(57)
Debt financing costs	(3)	(5)	(40)
Purchase of non-controlling interest	0	0	(78)
Net cash from financing activities	113	(226)	1,817
Effect of currency translation on cash	(7)	8	0
Net change in cash and cash equivalents	75	(17)	95
Cash and cash equivalents at beginning of period	306	323	228
Cash and cash equivalents at end of period	$ 381	$ 306	$ 323

Basis of Presentation and Summary of Significant Accounting Policies

12 Months Ended

Sep. 29, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

1.	Basis of Presentation and Summary of Significant Accounting Policies

Background

Berry Global Group, Inc. (“Berry,” “we,” or the “Company”) is a leading global supplier of a broad range of innovative non-woven, flexible, and rigid products used every day within consumer and industrial end markets.

Basis of Presentation

Periods presented in these financial statements include fiscal periods ending September 29, 2018 (“fiscal 2018”), September 30, 2017 (“fiscal 2017”), and October 1, 2016 (“fiscal 2016”). The Company has recast certain prior period amounts to conform to current reporting. The Company’s customers are located principally throughout the U.S., without significant concentration with any one customer. The Company performs periodic credit evaluations of its customers’ financial condition and generally does not require collateral. Fiscal 2018 and fiscal 2017 were fifty-two week periods, and fiscal 2016 was a fifty-three week period. The Company has evaluated subsequent events through the date the financial statements were issued.

The consolidated financial statements include the accounts of Berry and its subsidiaries, all of which includes our wholly owned and majority owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation. Where our ownership of consolidated subsidiaries is less than 100% the non-controlling interests are reflected in Non-controlling interest.

Revenue Recognition

Revenue from the sales of products is recognized at the time title and risks and rewards of ownership pass to the customer, there is persuasive evidence of an arrangement, the sales price is fixed and determinable and collection is reasonably assured. Provisions for certain rebates, sales incentives, trade promotions, coupons, product returns and discounts to customers are accounted for as reductions in gross sales to arrive at net sales. In accordance with the Revenue Recognition standards of the Accounting Standards Codification (“Codification” or “ASC”), the Company provides for these items as reductions of revenue at the later of the date of the sale or the date the incentive is offered. These provisions are based on estimates derived from current program requirements and historical experience.

Shipping, handling, purchasing, receiving, inspecting, warehousing, and other costs of distribution are presented in Cost of goods sold in the Consolidated Statements of Income. The Company classifies amounts charged to its customers for shipping and handling in Net sales in the Consolidated Statements of Income.

Purchases of Raw Materials and Concentration of Risk

The Company’s most significant raw material used in the production of its products is plastic resin. The largest supplier of the Company’s total resin material requirements represented approximately 16% of purchases in fiscal 2018. The Company uses a variety of suppliers to meet its resin requirements.

Research and Development

Research and development costs are expensed when incurred. The Company incurred research and development expenditures of $45 million, $45 million, and $48 million in fiscal 2018, 2017, and 2016, respectively.

Share-Based Compensation

The Company utilizes the Black-Scholes option valuation model for estimating the fair value of stock options and amortizes the estimated fair value on a straight-line basis over the requisite service period. The share-based compensation plan is more fully described in Note 12.

Foreign Currency

For the non-U.S. subsidiaries that account in a functional currency other than U.S. Dollars, assets and liabilities are translated into U.S. Dollars using period-end exchange rates. Sales and expenses are translated at the average exchange rates in effect during the period. Foreign currency translation gains and losses are included as a component of Accumulated other comprehensive income (loss) within stockholders’ equity. Gains and losses resulting from foreign currency transactions are included in the Consolidated Statements of Income.

Cash and Cash Equivalents

All highly liquid investments purchased with a maturity of three months or less from the time of purchase are considered to be cash equivalents.

Allowance for Doubtful Accounts

The Company’s accounts receivable and related allowance for doubtful accounts are analyzed in detail on a quarterly basis and all significant customers with delinquent balances are reviewed to determine future collectability. The determinations are based on legal issues (such as bankruptcy status), past history, current financial and credit agency reports, and the experience of the credit representatives. Reserves are established in the quarter in which the Company makes the determination that the account is deemed uncollectible. The Company maintains additional reserves based on its historical bad debt experience. The following table summarizes the activity for fiscal years ended for the allowance for doubtful accounts:

	2018			2017			2016
Allowance for doubtful accounts, beginning	$	13		$	8		$	3
Acquisition allowance for doubtful accounts		2			5			6
Bad debt expense		1			1			1
Write-offs against allowance		(3	)		(1	)		(2	)
Allowance for doubtful accounts, ending	$	13		$	13		$	8

Accounts Receivable Factoring Agreements

The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold.

There were no amounts outstanding from financial institutions related to U.S. based programs at September 29, 2018 or September 30, 2017. Gross amounts factored under these U.S. based programs at September 29, 2018 and September 30, 2017 were $162 million and $129 million, respectively. The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

Inventories

Inventories are stated at the lower of cost or market and are valued using the first-in, first-out method. Management periodically reviews inventory balances, using recent and future expected sales to identify slow-moving and/or obsolete items. The cost of spare parts is charged to cost of goods sold when purchased. We evaluate our reserve for inventory obsolescence on a quarterly basis and review inventory on-hand to determine future salability. We base our determinations on the age of the inventory and the experience of our personnel. We reserve inventory that we deem to be not salable in the quarter in which we make the determination. We believe, based on past history and our policies and procedures, that our net inventory is salable. Inventory as of fiscal 2018 and 2017 was:

Inventories:	2018		2017
Finished goods	$	503	$	428
Raw materials		384		334
	$	887	$	762

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Depreciation is computed primarily by the straight-line method over the estimated useful lives of the assets ranging from 15 to 40 years for buildings and improvements, 2 to 20 years for machinery, equipment, and tooling, and over the term of the agreement for capital leases. Leasehold improvements are depreciated over the shorter of the useful life of the improvement or the lease term. Repairs and maintenance costs are charged to expense as incurred. The Company capitalized interest of $9 million, $7 million, and $6 million in fiscal 2018, 2017, and 2016, respectively. Property, plant and equipment as of fiscal 2018 and 2017 was:

Property, plant and equipment:	2018			2017
Land, buildings and improvements	$	875		$	792
Equipment and construction in progress		4,242			3,895
		5,117			4,687
Less accumulated depreciation		(2,629	)		(2,321	)
	$	2,488		$	2,366

Long-lived Assets

Long-lived assets, including property, plant and equipment and definite lived intangible assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment," whenever facts and circumstances indicate that the carrying amount may not be recoverable. Specifically, this process involves comparing an asset’s carrying value to the estimated undiscounted future cash flows the asset is expected to generate over its remaining life. If this process were to result in the conclusion that the carrying value of a long-lived asset would not be recoverable, a write-down of the asset to fair value would be recorded through a charge to operations. Fair value is determined based upon discounted cash flows or appraisals as appropriate. Long-lived assets that are held for sale are reported at the lower of the assets’ carrying amount or fair value less costs related to the assets’ disposition. We recorded impairment charges totaling $2 million and $3 million to property, plant and equipment assets to their net realizable valuables in connection with facility shutdowns during fiscal years 2017 and 2016, respectively. Impairment charges are recorded in Other expense (income), net in the Consolidated Statements of Income. There were no impairments in fiscal 2018.

Goodwill

The Company follows the principles provided by ASC 350, "Intangibles - Goodwill and Other." Goodwill is not amortized but rather reviewed annually for impairment. The Company performed its annual impairment evaluation on the first day of the fourth fiscal quarter. For purposes of conducting our annual goodwill impairment test, the Company determined that we have seven reporting units, Health, Hygiene & Specialties (“HHS”) – North America ("NA"), HHS – South America ("SA"), HHS – Europe ("EU"), HHS – Asia ("AS"), Consumer Packaging, Engineered Materials, and Tapes. We determined that each of the components within our respective reporting units should be aggregated for our Consumer Packaging, Engineered Materials and Tapes reporting units. We reached this conclusion because within each of these three reporting units, we have similar products, management oversight, production processes, markets served, and/or common geographic region which allow us to share resources across the product lines. We regularly re-align our production equipment and manufacturing facilities in order to take advantage of cost savings opportunities, obtain synergies and create manufacturing efficiencies. In addition, we utilize our research and development centers, design center, tool shops, and graphics center which all provide benefits to each of the reporting units and work on new products that can benefit multiple product lines. We also believe that the goodwill is recoverable from the overall operations of the unit given our synergies from leveraging the combined resources, common raw materials, common research and development, similar margins and similar distribution methodologies. In our HHS segment, we operate in four geographical regions where our management teams for each geography oversee the operations and allocate the resources across the entire region. In fiscal year 2018, the Company applied the qualitative assessment and concluded that it was more likely than not that the fair value of each reporting unit exceeded the carrying amount except for the HHS-SA reporting unit due to continued macroeconomic pressures in South America. The Company completed step one in fiscal 2018, which concluded the fair value of the HHS-SA reporting unit exceeded its carrying value by 11% and thus no impairment was recorded. However, future declines in valuation market multiples, sustained lower earnings, or macroeconomic challenges could impact future impairment tests. In fiscal year 2017, the Company applied the qualitative assessment and concluded that it was more likely than not that the fair value of each reporting unit exceeded the carrying amount except for the HHS-SA and HHS-AS reporting units due to prior year quantitative tests performed and macroeconomic pressures in South America. The Company completed step one in fiscal 2017, which concluded the fair value of the HHS-SA and HHS-AS reporting units exceeded their carrying value by 9% and 49%, respectively, and thus no impairment was recorded. In fiscal year 2016, due to the segment realignment, the Company opted to perform a step one quantitative evaluation in accordance with ASC 350 to establish a baseline for the fair value of each reporting unit. The Company utilizes a combination of the discounted cash flow analysis and comparable company valuation methods to determine the fair values of its reporting units in accordance with ASC 820. The Company determined that the fair value of each reporting unit exceeded its carrying amount. The Company has recognized cumulative goodwill impairment charges of $165 million, which occurred in fiscal 2011.

The changes in the carrying amount of goodwill by reportable segment are as follows:

	Consumer Packaging			Health, Hygiene & Specialties			Engineered Materials			Total
Balance as of fiscal 2016	$	1,520		$	801		$	85		$	2,406
Segment re-alignment		(110	)		7			103			—
Foreign currency translation adjustment		1			11			(1	)		11
Acquisitions, net		—			—			358			358
Balance as of fiscal 2017	$	1,411		$	819		$	545		$	2,775
Foreign currency translation adjustment		(2	)		(26	)		1			(27	)
Acquisitions, net		—			109			87			196
Balance as of fiscal 2018	$	1,409		$	902		$	633		$	2,944

Deferred Financing Fees

Deferred financing fees are amortized to interest expense using the effective interest method over the lives of the respective debt agreements. Pursuant to ASC 835-30 the Company presents $43 million of debt issuance and deferred financing costs on the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge.

Intangible Assets

Customer relationships are being amortized using an accelerated amortization method which corresponds with the customer attrition rates used in the initial valuation of the intangibles over the estimated life of the relationships which range from 5 to 15 years. Definite lived trademarks are being amortized using the straight-line method over the estimated life of the asset which is not more than 15 years. Other intangibles, which include technology and licenses, are being amortized using the straight-line method over the estimated life of the asset which ranges from 5 to 14 years. The Company evaluates the remaining useful life of intangible assets on a periodic basis to determine whether events and circumstances warrant a revision to the remaining useful life. Certain trademarks that are expected to remain in use, which are indefinite lived intangible assets, are required to be reviewed for impairment annually. The Company has trademarks that total approximately $248 million that are indefinite lived and we test annually for impairment on the first day of the fourth quarter. We completed the annual impairment test of our indefinite lived trade names utilizing the relief from royalty method and noted no impairment in fiscal 2018, 2017 and 2016.

	Customer Relationships			Trademarks			Other Intangibles			Accumulated Amortization			Total
Balance as of fiscal 2016	$	1,690		$	326		$	182		$	(998	)	$	1,200
Adjustment for income taxes		—			1			—			—			1
Foreign currency translation adjustment		6			(1	)		1			(3	)		3
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		226			9			1			—			236
Balance as of fiscal 2017	$	1,922		$	335		$	184		$	(1,155	)	$	1,286

Foreign currency translation adjustment		(17	)		(1	)		(2	)		8			(12	)
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		177			9			34			—			220
Netting of fully amortized intangibles		(200	)		(50	)		(31	)		281			—
Balance as of fiscal 2018	$	1,882		$	293		$	185		$	(1,020	)	$	1,340

Insurable Liabilities

The Company records liabilities for the self-insured portion of workers’ compensation, health, product, general and auto liabilities. The determination of these liabilities and related expenses is dependent on claims experience. For most of these liabilities, claims incurred but not yet reported are estimated based upon historical claims experience.

Income Taxes

The Company accounts for income taxes under the asset and liability approach, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequence of events that have been recognized in the Company’s financial statements or income tax returns. Income taxes are recognized during the period in which the underlying transactions are recorded. Deferred taxes, with the exception of non-deductible goodwill, are provided for temporary differences between amounts of assets and liabilities as recorded for financial reporting purposes and such amounts as measured by tax laws. If the Company determines that a deferred tax asset arising from temporary differences is not likely to be utilized, the Company will establish a valuation allowance against that asset to record it at its expected realizable value. The Company recognizes uncertain tax positions when it is more likely than not that the tax position will be sustained upon examination by relevant taxing authorities, based on the technical merits of the position. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company’s effective tax rate is dependent on many factors including: the impact of enacted tax laws in jurisdictions in which the Company operates; the amount of earnings by jurisdiction, due to varying tax rates in each country; and the Company’s ability to utilize foreign tax credits related to foreign taxes paid on foreign earnings that will be remitted to the U.S.

Comprehensive Income (Loss)

Comprehensive income (loss) is comprised of net income and other comprehensive income (loss). Other comprehensive losses include net unrealized gains or losses resulting from currency translations of foreign subsidiaries, changes in the value of our derivative instruments and adjustments to the pension liability.

The accumulated balances related to each component of other comprehensive income (loss) were as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance as of fiscal 2015	$	(81	)	$	(25	)	$	(13	)	$	(119	)
Other comprehensive loss		(1	)		(25	)		(30	)		(56	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			2			16			18
Provision for income taxes		—			4			5			9
Balance as of fiscal 2016	$	(82	)	$	(44	)	$	(22	)	$	(148	)
Other comprehensive income		34			25			7			66
Net amount reclassified from accumulated other comprehensive income (loss)		—			13			21			34
Provision for income taxes		—			(10	)		(10	)		(20	)
Balance as of fiscal 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss)		(127	)		9			46			(72	)
Net amount reclassified from accumulated other comprehensive income (loss) ^(a)		—			(6	)		3			(3	)
Provision for income taxes		—			—			(13	)		(13	)
Balance as of fiscal 2018	$	(175	)	$	(13	)	$	32		$	(156	)

(a)	See Note 4 for further discussion on amounts reclassified out of accumulated other comprehensive income (loss) related to interest rate swaps and Note 9 for amounts reclassified related to pensions.

Accrued Rebates

The Company offers various rebates to customers based on purchases. These rebate programs are individually negotiated with customers and contain a variety of different terms and conditions. Certain rebates are calculated as flat percentages of purchases, while others included tiered volume incentives. These rebates may be payable monthly, quarterly, or annually. The calculation of the accrued rebate balance involves management estimates, especially where the terms of the rebate involve tiered volume levels that require estimates of expected annual sales. These provisions are based on estimates derived from current program requirements and historical experience. The accrual for customer rebates was $58 million and $58 million at the end of fiscal 2018 and 2017, respectively and is included in Accrued expenses and other current liabilities.

Pension

Pension benefit costs include assumptions for the discount rate, retirement age, and expected return on plan assets. Retiree medical plan costs include assumptions for the discount rate, retirement age, and health-care-cost trend rates. Periodically, the Company evaluates the discount rate and the expected return on plan assets in its defined benefit pension and retiree health benefit plans. In evaluating these assumptions, the Company considers many factors, including an evaluation of the discount rates, expected return on plan assets and the health-care-cost trend rates of other companies; historical assumptions compared with actual results; an analysis of current market conditions and asset allocations; and the views of advisers.

Net Income Per Share

The Company calculates basic net income per share based on the weighted-average number of outstanding common shares. The Company calculates diluted net income per share based on the weighted-average number of outstanding common shares plus the effect of dilutive securities.

Use of Estimates

The preparation of the financial statements in conformity with U.S. generally accepted accounting principles requires management to make extensive use of estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities and the reported amounts of sales and expenses. Actual results could differ materially from these estimates. Changes in estimates are recorded in results of operations in the period that the event or circumstances giving rise to such changes occur.

Recently Issued Accounting Pronouncements

Revenue Recognition

In May 2014, the Financial Accounting Standards Board (FASB) issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In order to do so, an entity would follow the five-step process for in-scope transactions: 1) identify the contract with a customer, 2) identify the separate performance obligations in the contract, 3) determine the transaction price, 4) allocate the transaction price to the separate performance obligations in the contract, and 5) recognize revenue when (or as) the entity satisfies a performance obligation. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings.

The Company conducted an evaluation of contracts with key customers and the provisions under the five-step model specified by the new standard. The majority of the Company’s revenue transactions consist of a single performance obligation to transfer promised goods for which revenue will be recorded consistently under both existing GAAP and the new standard. The Company evaluated whether the adoption may require acceleration of revenue for products produced by the Company without an alternative use and when the Company would have a legally enforceable right of payment. Based on the Company's contract reviews, relevant laws, operational interviews, and other procedures, the Company concluded that the acceleration of revenue is required on a small number of contracts, the effects of which are not material. Accordingly, the new standard does not have a material effect on the Company's financial statements. However, adoption of the new standard will result in expanded revenue disclosures beginning in fiscal 2019. The Company plans to adopt the new standard which will be effective for the Company beginning in fiscal 2019 using the modified retrospective approach.

Leases

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows. Companies may adopt this standard using a modified retrospective approach or by applying a prospective approach with a cumulative-effect adjustment in the opening balance of retained earnings in the period of adoption. Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact of this standard, which will not be effective for the Company until fiscal 2020.

Retirement Benefits

In March 2017, the FASB issued ASU 2017-07, Compensation – Retirement Benefits (Topic 715), Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers to report the service cost component in the same line item as other compensation costs arising from services rendered by the pertinent employees during the period. The other components of net benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations. If a separate line item is not used to present the other components of net benefit cost, then the line item used in the income statement to present the other components of net benefit cost must be disclosed. The new standard is effective for interim and annual periods beginning after December 15, 2017 and should be applied on a retrospective basis. Early adoption is permitted. The Company does not expect the adoption of this standard to have a material impact on our disclosures.

Hedges

In August 2017, the FASB issued ASU 2017-12, Targeted Improvements to Accounting for Hedging Activities in order to more closely align the results of hedge accounting with risk management activities through changes to the designation and measurement standard. The new standard is effective for interim and annual periods beginning after December 15, 2018. The effect of adoption should be reflected on all active hedges as of the beginning of the fiscal year of adoption. Early adoption is permitted. The Company has chosen to early adopt this standard for fiscal 2018, and did not experience a material impact on any of its active hedges.

Fair Value

In August 2018, the FASB issued ASU 2018-13, Changes to the Disclosure Requirements for Fair Value Measurement. The new standard modifies disclosure requirements including removing requirements to disclose the valuation process for Level 3 measurements and adding requirements to disclose the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements and the range and weighted average of significant unobservable inputs used to develop Level 3 measurements. The new standard is effective for interim and annual periods beginning after December 15, 2019. The Company is currently evaluating the impact of the adoption of this standard to our disclosures.

Defined Benefit Plans

In August 2018, the FASB issued ASU 2018-14, Changes to the Disclosure Requirements for Defined Benefit Plans. The new standard removes requirements to disclose the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year and the effects of a one-percentage-point changes in assumed health care cost trend rates. The standard also adds requirements to disclose the reasons for significant gains and losses related to changes in the benefit obligations for the period and the accumulated benefit obligation (ABO) for plans with ABOs in excess of plan assets. The new standard will be effective for fiscal years ending after December 15, 2020. The Company is currently evaluating the impact of the adoption of this standard to our disclosures.

Acquisitions

12 Months Ended

Sep. 29, 2018

Acquisitions [Abstract]

Acquisitions

2.	Acquisitions

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment. Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company used existing liquidity. The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates of fair value at the acquisition date. The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition. The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed. The assets acquired and liabilities assumed consisted of working capital of $26 million, property and equipment of $39 million, intangible assets of $95 million, and goodwill of $82 million. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million, which is preliminary and subject to adjustment. Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel. The acquired business is operated within our Health, Hygiene & Specialties segment. To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary fair values at the acquisition date. The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition. The Company has not finalized the allocation of the purchase price to the fair value of deferred taxes (including the assessment of uncertain tax positions), fixed assets, and certain working capital accounts. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes. The following table summarizes the preliminary purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		110
Other assets and long-term liabilities		6

(a)	Includes a $3 million step up of inventory to fair value

Adchem Corp

In June 2017, the Company acquired Adchem Corp's (“Adchem”) tapes business for a purchase price of $49 million. Adchem is a leader in the development of high performance adhesive tape systems for the automotive, construction, electronics, graphic arts, medical and general tape markets. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company used existing liquidity. The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair value estimates as of the acquisition date. The assets and assumed liabilities consisted of working capital of $10 million, property and equipment of $2 million, intangible assets of $22 million, and goodwill of $15 million. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

AEP Industries Inc.

In January 2017, the Company acquired AEP Industries Inc. (“AEP”) for a purchase price of $791 million, net of cash acquired. A portion of the purchase price consisted of issuing 6.4 million of Berry common shares which were valued at $324 million at the time of closing. AEP manufactures and markets an extensive and diverse line of polyethylene and polyvinyl chloride flexible plastic packaging products for consumer, industrial, and agricultural applications. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company entered into an incremental assumption agreement to increase the commitments under the Company's existing term loan credit agreement by $500 million due 2024.

When including AEP results for periods prior to the acquisition date, unaudited pro forma net sales were $7.4 billion and $7.6 billion for fiscal 2017 and fiscal 2016, respectively. Unaudited pro forma net income was $338 million and $250 million for fiscal 2017 and fiscal 2016, respectively. The unaudited pro forma net sales and net income assume that the acquisition had occurred as of the beginning of the period.

The unaudited pro forma information presented above is for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the AEP acquisition been consummated at the beginning of the period, nor is it necessarily indicative of future operating results. Further, the information reflects only pro forma adjustments for additional interest expense, depreciation, and amortization, net of the applicable income tax effects.

Long-Term Debt

12 Months Ended

Sep. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

3.	Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	September 29, 2018			September 30, 2017
Term loan	February 2020	$	800		$	1,000
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,645
Term loan	January 2024		493			498
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			—
Debt discounts and deferred fees			(43	)		(48	)
Capital leases and other	Various		135			132
Total long-term debt			5,844			5,641
Current portion of long-term debt			(38	)		(33	)
Long-term debt, less current portion		$	5,806		$	5,608

Fiscal 2018 Activity

In January 2018, the Company issued $500 million aggregate principal amount of 4.50% second priority senior secured notes due 2026. Interest on these notes is due semiannually in February and August. The Company recognized $4 million of debt discount related to this offering. The net proceeds were used to fund the Clopay acquisition.

Berry Global, Inc. Senior Secured Credit Facility

Our wholly owned subsidiary Berry Global, Inc.’s senior secured credit facilities consist of $3.7 billion of term loans and a $750 million asset-based revolving line of credit. The availability under the revolving line of credit is the lesser of $750 million or based on a defined borrowing base which is calculated based on available accounts receivable and inventory.

Based on market conditions, from time to time, the Company may reprice existing term loans in order to lower interest rates. As a result of repricing activities, the term loans with a maturity date of February 2020 and January 2021 bear interest at LIBOR plus 1.75%. The term loans with a maturity date of October 2022 and January 2024 bear interest at LIBOR plus 2.00%. Related to these repricings, the Company recorded a loss on debt extinguishment of $2 million, $10 million, and $4 million in fiscal 2018, 2017, and 2016, respectively, in Other expense (income), net in the Consolidated Statements of Income.

The term loan facility requires minimum quarterly principal payments, with the remaining amount payable upon maturity. The Company may voluntarily repay outstanding loans under the senior secured credit facilities at any time without premium or penalty, other than customary “breakage” costs with respect to eurodollar loans. All obligations under the senior secured credit facilities are unconditionally guaranteed by the Company and, subject to certain exceptions, each of the Company’s existing and future direct and indirect domestic subsidiaries. The guarantees of those obligations are secured by substantially all of the Company’s assets as well as those of each domestic subsidiary guarantor. During fiscal 2018, the Company made $335 million of repayments on long-term borrowings using existing liquidity.

Despite not having financial maintenance covenants, our debt agreements contain certain negative covenants. We are in compliance will all covenants as of September 29, 2018. The failure to comply with these negative covenants could restrict our ability to incur additional indebtedness, effect acquisitions, enter into certain significant business combinations, make distributions or redeem indebtedness.

Future maturities of long-term debt as of fiscal year end 2018 are as follows:

Fiscal Year	Maturities
2019	$	38
2020		837
2021		842
2022		27
2023		2,458
Thereafter		1,685
	$	5,887

Interest paid was $253 million, $288 million, and $276 million in fiscal 2018, 2017, and 2016, respectively.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion in the Consolidated Balance Sheet and are amortized to Interest expense through maturity.

Financial Instruments and Fair Value Measurements

12 Months Ended

Sep. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

4.	Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, are recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

In November 2017, the Company entered into certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro denominated debt. The swap agreements mature in May 2022. The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans. Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable).

In February 2013, the Company entered into a $1 billion interest rate swap transaction with an effective date of May 2016 and expiration in May 2019. In June 2013, the Company elected to settle this derivative instrument and received $16 million as a result of this settlement. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense from May 2016 through May 2019, the original term of the swap agreement.

During fiscal 2017 the Company modified various term loan rates and maturities. In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as an effective cash flow hedges. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

In June 2018, the Company elected to settle two of its derivative instruments with expiration dates in June 2019 and September 2021, and received $9 million and $21 million, respectively. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the original expiration dates for of each of the swap agreements. The Company also entered into a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date of June 2018 and expiration in September 2021.

As of fiscal 2018, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000% with an effective date in May 2017 and expiration in May 2022 and (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows;

Derivatives Instruments	Hedge Designation	Balance Sheet Location	2018		2017
Cross-currency swaps	Designated	Other long-term liabilities	$	11	$	—
Interest rate swaps	Designated	Other assets		16		1
Interest rate swaps	Not designated	Other assets		—		13
Interest rate swaps	Designated	Other long-term liabilities		—		15
Interest rate swaps	Not designated	Other long-term liabilities		1		13

The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows:

		Fiscal years ended
Derivatives instruments	Statement of Income Location	September 29, 2018			September 30, 2017			October 1, 2016
Cross-currency swaps	Interest expense, net	$	(5	)	$	—		$	—
Foreign currency swaps	Other (income) expense		—			(2	)		13
Interest rate swaps	Interest expense, net	$	(1	)	$	24		$	16

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $11 million in the next 12 months. The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate swap agreements and capital lease obligations. The fair value of our long-term indebtedness exceeded book value by $5 million as of fiscal 2018, and $81 million as of fiscal 2017. The Company’s long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. See Note 2 for discussion of our acquisitions and the non-recurring fair value measurement considerations that were utilized in the purchase price allocation. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year, and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018, 2017, and 2016 assessments.

Included in the following tables are the major categories of assets and their current carrying values that were measured at fair value on a non-recurring basis in the current year, along with the impairment loss recognized on the fair value measurement for the fiscal years then ended:

	As of the end of fiscal 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

	As of the end of fiscal 2017
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,775		2,775		—
Definite lived intangible assets		—		—		1,038		1,038		—
Property, plant and equipment		—		—		2,366		2,366		2
Total	$	—	$	—	$	6,427	$	6,427	$	2

	As of the end of fiscal 2016
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,406		2,406		—
Definite lived intangible assets		—		—		952		952		—
Property, plant and equipment		—		—		2,224		2,224		3
Total	$	—	$	—	$	5,830	$	5,830	$	3

Valuation of Goodwill and Indefinite Lived Intangible Assets

ASC Topic 350 requires the Company to test goodwill for impairment at least annually. The Company conducted the impairment test on the first day of the fourth fiscal quarter, unless indications of impairment exist during an interim period. When assessing its goodwill for impairment, the Company utilizes a comparable company market approach weighted equally with a discounted cash flow analysis to determine the fair value of their reporting units and corroborate the fair values. The Company utilizes a relief from royalty method to value their indefinite lived trademarks and uses the forecasts that are consistent with those used in the reporting unit analysis (Note 1).

Valuation of Property, Plant and Equipment and Definite Lived Intangible Assets

The Company periodically realigns their manufacturing operations which results in facilities being closed and shut down and equipment transferred to other facilities or equipment being scrapped or sold. The Company utilizes appraised values to corroborate the fair value of the facilities and has utilized a scrap value based on prior facility shut downs to estimate the fair value of the equipment, which has approximated the actual value that was received. When impairment indicators exist, the Company will also perform an undiscounted cash flow analysis to determine the recoverability of the Company’s long-lived assets. The Company incurred impairment charges of $2 million and $3 million related to property, plant and equipment in fiscal years 2017 and 2016, respectively. The Company did not incur an impairment charge on definite lived intangible assets in fiscal 2018, 2017, or 2016.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Lease and Other Commitments and Contingencies

12 Months Ended

Sep. 29, 2018

Lease and Other Commitments and Contingencies [Abstract]

Lease and Other Commitments and Contingencies

6.	Lease and Other Commitments and Contingencies

The Company leases certain property, plant and equipment under long-term lease agreements. Property, plant, and equipment under capital leases are reflected on the Company’s balance sheet in property and equipment. The Company entered into new capital lease obligations totaling $31 million, $5 million, and $51 million during fiscal 2018, 2017, and 2016, respectively, with various lease expiration dates through 2027. The Company records amortization of capital leases in Cost of goods sold in the Consolidated Statement of Income. Assets under operating leases are not recorded on the Company’s balance sheet. Operating leases expire at various dates in the future with certain leases containing renewal options. The Company had minimum lease payments or contingent rentals of $29 million and $27 million and asset retirement obligations of $10 million and $9 million as of fiscal 2018 and 2017, respectively. Total rental expense from operating leases was $72 million, $67 million, and $60 million in fiscal 2018, 2017, and 2016, respectively.

Future minimum lease payments for capital leases and non-cancellable operating leases with initial terms in excess of one year as of fiscal year end 2018 are as follows:

	Capital Leases			Operating Leases
2019	$	37		$	67
2020		32			56
2021		27			51
2022		24			44
2023		10			37
Thereafter		19			165
		149		$	420
Less: amount representing interest		(14	)
Present value of net minimum lease payments	$	135

The Company has entered into a series of sale-leaseback transactions, pursuant to which it sold certain facilities and is leasing these facilities back. The Company has a total deferred gain on these sale-leaseback transactions of $21 million at the end of fiscal 2018, and is amortizing this over the respective lease of the facility.

The Company also has various purchase commitments for raw materials, supplies and property and equipment incidental to the ordinary conduct of business.

Litigation

The Company is party to various legal proceedings in addition to the above involving routine claims which are incidental to its business. Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, the Company believes that any ultimate liability would not be material to its financial position, results of operations or cash flows.

Collective Bargaining Agreements

At the end of fiscal 2018, we employed approximately 24,000 employees, and approximately 18% of those employees are covered by collective bargaining agreements. The majority of these agreements are due for renegotiation in fiscal 2019. Our relations with employees under collective bargaining agreements remain satisfactory and there have been no significant work stoppages or other labor disputes during the past three years.

Income Taxes

12 Months Ended

Sep. 29, 2018

Income Taxes [Abstract]

Income Taxes

8.	Income Taxes

The Company is being taxed at the U.S. corporate level as a C-Corporation and has provided U.S. Federal, State and foreign income taxes.

In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering U.S. corporate income tax rates. As the Company has a September fiscal year-end, the lower corporate income tax rate will be phased in during fiscal 2018 and will be 21% in subsequent years. Partially offsetting the lower corporate income tax, the Tax Act also eliminates certain domestic deductions that were previously included in our estimated annual tax rate. As part of the transition to the new tax system, the Tax Act (i) imposes a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries; (ii) requires the Company revalue our U.S. net deferred tax liability position to the lower federal base rate of 21% and (iii) imposes a tax on global intangible low-taxed income provisions (“GILTI”), which is applicable beginning in fiscal 2019. Given the complexity of the GILTI provisions, we are still evaluating its effects and have not yet determined our accounting policy.

The transitional impacts of the Tax Act resulted in a transition benefit of $124 million in fiscal 2018, which includes an estimated repatriation tax charge of $21 million (comprised of the U.S. repatriation taxes and foreign withholding taxes) and an estimated net benefit of $145 million from all other changes, including the estimated benefit from revaluing deferred taxes to the lower rate. The impact of the corporate income tax net reduction along with the transitional taxes were recorded to the Consolidated Statements of Income.

The ultimate impacts of the Tax Act may differ from the provisional amount due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the Tax Act. The accounting is expected to be complete by the end of our first quarter of fiscal 2019.

Significant components of income tax expense for the fiscal years ended are as follows:

	2018			2017			2016
Current
U.S.
Federal	$	19		$	40		$	—
State		8			6			5
Non-U.S.		40			58			36
Total current		67			104			41
Deferred:
U.S.
Federal		(72	)		34			35
State		12			(10	)		3
Non-U.S.		(26	)		(19	)		(7	)
Total deferred		(86	)		5			31
Expense for income taxes	$	(19	)	$	109		$	72

U.S. income from continuing operations before income taxes was $373 million, $313 million, and $168 million for fiscal 2018, 2017, and 2016, respectively. Non-U.S. income from continuing operations before income taxes was $104 million, $136 million, and $140 million for fiscal 2018, 2017, and 2016, respectively.

The reconciliation between U.S. Federal income taxes at the statutory rate and the Company’s benefit for income taxes on continuing operations for fiscal year end is follows:

	2018			2017			2016
U.S. Federal income tax expense at the statutory rate	$	117		$	157		$	108
Adjustments to reconcile to the income tax provision:
U.S. state income tax expense		12			6			8
Changes in state valuation allowance		—			(9	)		2
Research and development credits		(7	)		(7	)		(8	)
Share-based compensation		(8	)		(33	)		(15	)
U.S. tax reform		(124	)		—			—
Permanent differences		—			2			2
Changes in foreign valuation allowance		(10	)		3			(1	)
Foreign income taxed in the U.S.		—			—			7
Manufacturing tax benefits		(6	)		(6	)		—
Deduction of worthless investment		—			—			(9	)
Permanent foreign currency differences		—			(1	)		(8	)
Rate differences between U.S. and foreign		3			(11	)		(14	)
Other		4			8			—
Expense for income taxes	$	(19	)	$	109		$	72

Deferred income taxes result from temporary differences between the amount of assets and liabilities recognized for financial reporting and tax purposes. The components of the net deferred income tax liability as of fiscal year end are as follows:

	2018			2017
Deferred tax assets:
Allowance for doubtful accounts	$	4		$	7
Deferred gain on sale-leaseback		6			10
Accrued liabilities and reserves		28			89
Inventories		9			6
Net operating loss carryforward		212			292
Alternative minimum tax (AMT) credit carryforward		8			11
Research and development credit carryforward		13			18
Federal and state tax credits		10			9
Other		19			14
Total deferred tax assets		309			456
Valuation allowance		(93	)		(93	)
Total deferred tax assets, net of valuation allowance		216			363
Deferred tax liabilities:
Property, plant and equipment		239			277
Intangible assets		306			475
Debt extinguishment		—			27
Other		5			3
Total deferred tax liabilities		550			782
Net deferred tax liability	$	(334	)	$	(419	)

As of September 29, 2018, the Company had $31 million of net deferred tax assets recorded in Other assets, and $365 million of net deferred tax liabilities recorded in Deferred income taxes on the Consolidated Balance Sheets.

After Internal Revenue Code Section 382 (“Section 382”) limitations, the Company has $357 million of U.S. federal net operating loss carryforwards as of fiscal 2018, which will be available to offset future taxable income. As of fiscal year end 2018, the Company had state and foreign net operating loss carryforwards of $1,114 million and $322 million, respectively, which will be available to offset future taxable income. If not used, the federal net operating loss carryforwards will expire in future years beginning 2024 through 2035. As a result of the elimination of AMT in the Tax Act, the Company's current AMT credit carryforwards totaling $8 million are available through the 2022 tax year to reduce those years’ federal income taxes, after which any unclaimed balance becomes fully refundable. The state net operating loss carryforwards will expire in future years beginning in 2018 through 2036. The foreign net operating loss carryforwards will expire in future years beginning in 2018 while a portion remains available indefinitely. The Company has $13 million of state Research and Development tax credits that will expire in future years beginning 2027 through 2037. In addition, the Company has $10 million of other state tax credits that will expire in future years beginning in 2019 through 2020.

In connection with the initial public offering, the Company entered into an income tax receivable agreement that provides for the payment to pre-initial public offering stockholders, option holders and holders of our stock appreciation rights, 85% of the amount of cash savings, if any, in U.S. federal, foreign, state and local income tax that are actually realized (or are deemed to be realized in the case of a change of control) as a result of the utilization of our and our subsidiaries’ net operating losses attributable to periods prior to the initial public offering. Based on the Company's assumptions using various items, including valuation analysis and current tax law, the Company recorded an obligation of $313 million which was recognized as a reduction of Paid-in capital on the Consolidated Balance Sheets. The Company made payments of $37 million, $111 million, and $57 million in fiscal years 2018, 2017, and 2016, respectively. The balance at the end of fiscal 2018 was $39 million, and the Company made its fiscal 2019 payment of $16 million in October 2018.

The Company believes that it will not generate sufficient future taxable income to realize the tax benefits in certain foreign jurisdictions related to the deferred tax assets. The Company also has certain state net operating losses that may expire before they are fully utilized. Therefore, the Company has provided a valuation allowance against certain of its foreign deferred tax assets and a valuation allowance against certain of its state deferred tax assets included within the deferred tax assets. The change in ownership of Avintiv created limitations under Sec. 382 of the Internal Revenue Code on annual usage of Avintiv's net operating loss carryforwards. All of the Company’s Federal net operating loss carryforwards should be available for use within the next 16 years and are not expected to expire unutilized. Prior to the Company's acquisition of Avintiv, Avintiv was subject to certain ownership changes that resulted in the effective loss of certain NOLs. The NOLs effectively lost have been excluded from the opening balance sheet of Avintiv. As part of the effective tax rate calculation, if we determine that a deferred tax asset arising from temporary differences is not likely to be utilized, we will establish a valuation allowance against that asset to record it at its expected realizable value. The Company has not provided a valuation allowance on its federal net operating loss carryforwards in the U.S. because it has determined that future reversals of its temporary taxable differences will occur in the same periods and are of the same nature as the temporary differences giving rise to the deferred tax assets. Our valuation allowance against deferred tax assets was $93 million as of the fiscal years ended 2018 and 2017, related to the foreign and U.S. state operations. The Company paid cash taxes of $60 million, $41 million, and $43 million in fiscal 2018, 2017, and 2016, respectively.

The one-time repatriation tax, created with the passage of the Tax Act, is based on our total post-1986 earnings and profits (E&P) that we previously deferred from U.S. income taxes. We recorded a provisional amount for our one-time repatriation tax liability resulting in an increase in income tax expense of $21 million (comprised of the U.S. repatriation taxes and foreign withholding taxes). No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax, or any additional outside basis difference inherent in these entities, as these amounts continue to be indefinitely reinvested in foreign operations.

Uncertain Tax Positions

ASC 740 prescribes a recognition threshold of more-likely-than not to be sustained upon examination as it relates to the accounting for uncertainty in income taxes recognized in an enterprise's financial statements. The Company's policy is to include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes.

The following table summarizes the activity related to our gross unrecognized tax benefits for fiscal year end:

	2018			2017
Beginning unrecognized tax benefits	$	59		$	62
Gross increases – tax positions in prior periods		1			1
Gross increases – current period tax positions		19			4
Gross decreases – tax positions in prior periods		—			(1	)
Settlements		—			(3	)
Lapse of statute of limitations		(5	)		(4	)
Ending unrecognized tax benefits	$	74		$	59

As of fiscal year end 2018, the amount of unrecognized tax benefits that, if recognized, would affect our effective tax rate was $72 million and we had $23 million accrued for payment of interest and penalties related to our uncertain tax positions. Our penalties and interest related to uncertain tax positions are included in income tax expense.

We and our subsidiaries are routinely examined by various taxing authorities. Although we file U.S. federal, U.S. state, and foreign tax returns, our major tax jurisdiction is the U.S. The IRS has completed an examination of our 2003, 2010 and 2011 tax years. Our 2004 – 2009, and 2012 – 2016 tax years remain subject to examination by the IRS. Avintiv's pre-acquisition U.S. federal tax returns for the years 2004 – 2015 remain subject to examination by the IRS. Companhia Providência Indústria e Comércio (“Providência”) was subject to certain tax claims at the time Providência was acquired by Avintiv and have been accounted for in the financial statements as a deferred purchase price liability. There are various other on-going audits in various other jurisdictions that are not material to our financial statements.

Retirement Plans

12 Months Ended

Sep. 29, 2018

Retirement Plans [Abstract]

Retirement Plans

9.	Retirement Plans

The Company maintains defined benefit pension plans globally, which cover certain manufacturing facilities. The Company also maintains retiree health plans, which cover certain healthcare and life insurance benefits for certain retired employees and their spouses. Each of the defined benefit and retiree health plans are frozen plans. The Company uses fiscal year end as a measurement date for the retirement plans.

The Company also sponsors defined contribution 401(k) retirement plans covering substantially all employees. Contributions are based upon a fixed dollar amount for employees who participate and percentages of employee contributions at specified thresholds. Contribution expense for these plans was $20 million, $18 million, and $10 million for fiscal 2018, 2017, and 2016, respectively.

The projected benefit obligations of the Company’s plans presented herein are equal to the accumulated benefit obligations of such plans. The net amount of liability recognized is included in Other long-term liabilities on the Consolidated Balance Sheets.

	Defined Benefit Pension Plans						Retiree Health Plans
	2018			2017			2018			2017
Change in Projected Benefit Obligations (PBO)

PBO at beginning of period	$	330		$	492		$	7		$	7
Interest cost		11			11			—			—
Actuarial loss (gain)		(17	)		(15	)		—			—
Plan conversion ^(a)		—			(139	)		—			—
Benefit settlements		—			(3	)		—			—
Benefits paid		(17	)		(16	)		(1	)		—
PBO at end of period	$	307		$	330		$	6		$	7

Change in Fair Value of Plan Assets

Plan assets at beginning of period	$	291		$	418		$	—		$	—
Actual return on plan assets		3			22			—			—
Company contributions		—			7			1			1
Plan conversion ^(a)		—			(136	)		—			—
Benefit settlements		—			(2	)		—			—
Benefits paid		(17	)		(18	)		(1	)		(1	)
Plan assets at end of period		277			291			—			—
Net amount recognized	$	(30	)	$	(39	)	$	(6	)	$	(7	)

(a)

During fiscal 2017, the Company contributed assets from a foreign defined benefit pension plan in order to convert the plan into a defined contribution plan. As a result of the transaction, the Company recognized a loss of $10 million related to the reclassification of amount previously deferred in Accumulated other comprehensive loss to the Consolidated Statements of Income.

At the end of fiscal 2018 the Company had $31 million of net unrealized losses recorded in Accumulated other comprehensive loss on the Consolidated Balance Sheets. The Company expects $2 million to be realized in fiscal 2019, and the remaining to be recognized over the next 11 fiscal years.

The following table presents significant weighted-average assumptions used to determine benefit obligation and benefit cost for the fiscal years ended:

	Defined Benefit Pension Plans				Retiree Health Plan
(Percentages)	2018		2017		2018		2017
Weighted-average assumptions:
Discount rate for benefit obligation		4.0		3.5		3.8		3.3
Discount rate for net benefit cost		3.5		3.2		3.3		2.9
Expected return on plan assets for net benefit costs		6.1		6.4		—		—

In evaluating the expected return on plan assets, Berry considered its historical assumptions compared with actual results, an analysis of current market conditions, asset allocations, and the views of advisors. The return on plan assets is derived from target allocations and historical yield by asset type. Health-care-cost trend rates were assumed to increase at an annual rate of 7.0%. A one-percentage-point change in these assumed health care cost trend rates would not have a material impact on our postretirement benefit obligation.

In accordance with the guidance from the FASB for employers’ disclosure about postretirement benefit plan assets the table below discloses fair values of each pension plan asset category and level within the fair value hierarchy in which it falls. There were no material changes or transfers between level 3 assets and the other levels, with the exception of the contribution of assets and conversion of the foreign defined benefit pension plan as described above.

Fiscal 2018 Asset Category	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	6	$	—	$	—	$	6
U.S. large cap comingled equity funds		—		67		—		67
U.S. mid cap equity mutual funds		50		—		—		50
U.S. small cap equity mutual funds		3		—		—		3
International equity mutual funds		15		—		—		15
Real estate equity investment funds		3		—		—		3
Corporate bond mutual funds		11		—		—		11
Corporate bonds		—		108		—		108
Guaranteed investment account		—		—		8		8
International fixed income funds		6		—		—		6
Total	$	94	$	175	$	8	$	277

Fiscal 2017 Asset Category	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	6	$	—	$	—	$	6
U.S. large cap comingled equity funds		—		61		—		61
U.S. mid cap equity mutual funds		57		—		—		57
U.S. small cap equity mutual funds		3		—		—		3
International equity mutual funds		14		—		—		14
Real estate equity investment funds		4		—		—		4
Corporate bond mutual funds		17		—		—		17
Corporate bonds		—		114		—		114
Guaranteed investment account		—		—		9		9
International fixed income funds		6		—		—		6
Total	$	107	$	175	$	9	$	291

The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid for the fiscal year end:

	Defined Benefit Pension Plans		Retiree Health Plan
2019	$	18	$	1
2020		18		1
2021		19		1
2022		19		—
2023		19		—
2024-2028		96		2

Net pension and retiree health benefit expense included the following components as of fiscal year end:

	2018			2017			2016
Service cost	$	—		$	—		$	3
Interest cost		11			11			16
Amortization of net actuarial loss		2			3			2
Expected return on plan assets		(17	)		(17	)		(20	)
Net periodic benefit cost	$	(4	)	$	(3	)	$	1

Our defined benefit pension plan asset allocations as of fiscal year end are as follows:

	2018			2017
Asset Category
Equity securities and equity-like instruments		50	%		48	%
Debt securities and debt-like		45			47
Other		5			5
Total		100	%		100	%

The Company’s retirement plan assets are invested with the objective of providing the plans the ability to fund current and future benefit payment requirements while minimizing annual Company contributions. The retirement plans held $43 million of the Company’s stock at the end of fiscal 2018. The Company re-addresses the allocation of its investments on a regular basis.

Restructuring and Impairment Charges

12 Months Ended

Sep. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring and Impairment Charges

10.	Restructuring and Impairment Charges

The Company has announced various restructuring plans in the last three fiscal years which included shutting down facilities in all three of the Company’s operating segments. In all instances, the majority of the operations from rationalized facilities was transferred to other facilities within the respective division.

During fiscal 2016, the Company shut down one facility in the Consumer Packaging division and announced the intention to shut down one additional Consumer Packaging facility. The two facilities accounted for approximately $36 million of annual net sales.

During fiscal 2017, the Company shut down one facility in the Health, Hygiene & Specialties division, which accounted for approximately $5 million of annual net sales, and completed the previously announced facility shut down in the Consumer Packaging division, which accounted for approximately $12 million of annual net sales.

During fiscal 2018, the Company shut down one facility in each of the Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging divisions, which accounted for approximately $10 million, $30 million, and $15 million of annual net sales, respectively.

Since 2016, total expected costs attributed to restructuring programs total $95 million with $3 million remaining to be recognized in the future.

	Expected Total Costs		Cumulative Charges through Fiscal 2018		To be Recognized in Future
Severance and termination benefits	$	75	$	75	$	—
Facility exit costs		15		12		3
Asset impairment		5		5		—
Total	$	95	$	92	$	3

The tables below sets forth the significant components of the restructuring charges recognized for the fiscal years ended, by segment:

	2018		2017		2016
Engineered Materials	$	6	$	5	$	3
Health, Hygiene & Specialties		27		11		20
Consumer Packaging		3		8		9
Consolidated	$	36	$	24	$	32

The table below sets forth the activity with respect to the restructuring charges and the impact on our accrued restructuring reserves:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance as of fiscal 2016	$	7		$	6		$	—		$	13
Acquisition		13			—			—			13
Charges		18			4			2			24
Non-cash asset impairment		—			—			(2	)		(2	)
Cash payments		(24	)		(5	)		—			(29	)
Balance as of fiscal 2017	$	14		$	5		$	—		$	19
Charges		34			2			—			36
Cash payments		(39	)		(3	)		—			(42	)
Balance as of fiscal 2018	$	9		$	4		$	—		$	13

Stockholders' Equity

12 Months Ended

Sep. 29, 2018

Stockholders' Equity [Abstract]

Stockholders' Equity

12.	Stockholders’ Equity

Share Repurchases

In August 2018, the Company announced that its Board authorized a $500 million share repurchase program. Share repurchases will be made through open market purchases, privately negotiated transactions, Rule 10b5-1 plans, or other transactions in accordance with applicable securities laws and in such amounts at such times as we deem appropriate based upon prevailing market and business conditions and other factors. The share repurchase program has no expiration date and may be suspended at any time.

During fiscal 2018, the Company repurchased approximately 731 thousand shares for $35 million, at an average price of $47.75. All share repurchases were immediately retired. Common stock was reduced by the number of shares retired at $0.01 par value per share. The Company allocates the excess purchase price over par value between additional paid-in capital and retained earnings.

Equity Incentive Plans

In fiscal 2018, the Company amended the 2015 Berry Global Group, Inc. Long-Term Incentive Plan to authorize the issuance of 12.5 million shares, an increase of 5 million shares from the previous authorization.

The Company recognized total share-based compensation expense of $23 million, $20 million, and $20 million for fiscal 2018, 2017, and 2016, respectively. The intrinsic value of options exercised in fiscal 2018 was $35 million.

Information related to the equity incentive plans as of the fiscal year end is as follows:

	2018					2017
	Number of Shares (in thousands)			Weighted Average Exercise Price		Number of Shares (in thousands)			Weighted Average Exercise Price
Options outstanding, beginning of period		10,760		$	28.18		11,716		$	21.44
Options granted		1,453			54.33		1,820			49.53
Options exercised		(1,176	)		18.62		(2,562	)		12.07
Options forfeited or cancelled		(293	)		41.30		(214	)		33.52
Options outstanding, end of period		10,744		$	32.40		10,760		$	28.18

Option price range at end of period	$	3.04-54.33				$	3.04-49.53
Options exercisable at end of period		5,154					4,108
Options available for grant at period end		6,422					2,875
Weighted average fair value of options granted during period	$	17.84				$	15.52

The fair value for options granted has been estimated at the date of grant using a Black-Scholes model, generally with the following weighted average assumptions:

	2018			2017			2016
Risk-free interest rate		2.7	%		2.2	%		1.2	%
Dividend yield		0.0	%		0.0	%		0.0	%
Volatility factor		26.1	%		26.0	%		25.7	%
Expected option life	6.5 years			6.5 years			6.5 years

For purposes of the valuation model in fiscal years 2018, 2017, and 2016, the Company used the simplified method due to the lack of historical data upon which to estimate the expected term.

The following table summarizes information about the options outstanding as of fiscal 2018:

Range of Exercise Prices				Number Outstanding (in thousands)				Intrinsic Value of Outstanding (in millions)			Weighted Remaining Contractual Life		Weighted Exercise Price				Number Exercisable (in thousands)				Intrinsic Value of Exercisable (in millions)				Unrecognized Compensation (in millions)			Weighted Recognition Period
$	3.04-54.33				10,744			$	172		6.5 years		$	32.40				5,154			$	120			$	25		1.9 years

Segment and Geographic Data

12 Months Ended

Sep. 29, 2018

Segment and Geographic Data [Abstract]

Segment and Geographic Data

13.	Segment and Geographic Data

Berry’s operations are organized into three reportable segments: Consumer Packaging, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us with our customers, provide improved service, and drive future growth in a cost efficient manner.

The Company has manufacturing and distribution centers in the U.S., Canada, Mexico, Belgium, France, Spain, United Kingdom, Italy, Germany, Brazil, Argentina, Colombia, Malaysia, India, China, and the Netherlands. The North American operation represents 82% of the Company’s net sales, 84% of total long-lived assets, and 84% of the total assets. Selected information by reportable segment is presented in the following tables:

	2018		2017		2016
Net sales
Engineered Materials	$	2,672	$	2,375	$	1,627
Health, Hygiene & Specialties		2,734		2,369		2,400
Consumer Packaging		2,463		2,351		2,462
Total	$	7,869	$	7,095	$	6,489

Operating income
Engineered Materials	$	368	$	316	$	182
Health, Hygiene & Specialties		202		216		196
Consumer Packaging		191		200		203
Total	$	761	$	732	$	581

Depreciation and amortization
Engineered Materials	$	109	$	106	$	82
Health, Hygiene & Specialties		200		184		199
Consumer Packaging		229		231		244
Total	$	538	$	521	$	525

	2018		2017
Total assets:
Engineered Materials	$	1,998	$	1,803
Health, Hygiene & Specialties		3,913		3,496
Consumer Packaging		3,220		3,177
Total assets	$	9,131	$	8,476
Goodwill:
Engineered Materials	$	633	$	545
Health, Hygiene & Specialties		902		819
Consumer Packaging		1,409		1,411
Total goodwill	$	2,944	$	2,775

Selected information by geography is presented in the following tables:

	2018		2017		2016
Net sales:
North America	$	6,474	$	5,850	$	5,250
South America		332		333		336
Europe		807		646		661
Asia		256		266		242
Total net sales	$	7,869	$	7,095	$	6,489

	2018		2017
Long-lived assets:
North America	$	5,764	$	5,303
South America		320		418
Europe		463		467
Asia		299		284
Total Long-lived assets	$	6,846	$	6,472

Selected information by product line is presented in the following tables:

(in percentages)	2018			2017			2016
Net sales:
Core Films		46	%		49	%		72	%
Retail & Industrial		54			51			28
Engineered Materials		100	%		100	%		100	%

Health		19	%		22	%		20	%
Hygiene		43			44			45
Specialties		38			34			35
Health, Hygiene & Specialties		100	%		100	%		100	%

Rigid Open Top		44	%		43	%		42	%
Rigid Closed Top		56			57			58
Consumer Packaging		100	%		100	%		100	%

Net Income per Share

12 Months Ended

Sep. 29, 2018

Net Income per Share [Abstract]

Net Income per Share

14.	Net Income per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is computed by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. There were no shares excluded from the calculations as the effect of their conversion into shares of our common stock would be antidilutive.

The following tables and discussion provide a reconciliation of the numerator and denominator of the basic and diluted net income per share computations.

(in millions, except per share amounts)	2018		2017		2016
Numerator
Net income attributable to the Company	$	496	$	340	$	236
Denominator
Weighted average common shares outstanding - basic		131.4		127.6		120.8
Dilutive shares		3.8		5.0		4.2
Weighted average common and common equivalent shares outstanding - diluted		135.2		132.6		125.0

Per common share income
Basic	$	3.77	$	2.66	$	1.95
Diluted	$	3.67	$	2.56	$	1.89

Guarantor and Non-Guarantor Financial Information

12 Months Ended

Sep. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

15.	Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees the Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility. Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries. The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures. The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements. The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries. All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Statements of Operations

	Fiscal 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	574		$	5,465		$	1,830		$	—		$	7,869
Cost of goods sold		—			346			4,558			1,534			—			6,438
Selling, general and administrative		—			63			309			108			—			480
Amortization of intangibles		—			1			127			26			—			154
Restructuring and impairment charges		—			—			20			16			—			36
Operating income		—			164			451			146			—			761
Other (income) expense, net		—			8			8			9			—			25
Interest expense, net		—			8			225			26			—			259
Equity in net income of subsidiaries		(477	)		(307	)		—			—			784			—
Income (loss) before income taxes		477			455			218			111			(784	)		477
Income tax expense (benefit)		(19	)		(41	)		(2	)		24			19			(19	)
Net income (loss)	$	496		$	496		$	220		$	87		$	(803	)	$	496
Currency translation		(127	)		(11	)		(3	)		(113	)		127			(127	)
Interest rate hedges		49			49			—			—			(49	)		49
Defined benefit pension and retiree health benefit plans		3			—			—			3			(3	)		3
Provision for income taxes related to other comprehensive income items		(13	)		(13	)		—			—			13			(13	)
Comprehensive income (loss)	$	408		$	521		$	217		$	(23	)	$	(715	)	$	408

	Fiscal 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	587		$	4,861		$	1,647	$	—		$	7,095
Cost of goods sold		—			438			3,920			1,333		—			5,691
Selling, general and administrative		—			55			335			104		—			494
Amortization of intangibles		—			6			120			28		—			154
Restructuring and impairment charges		—			—			14			10		—			24
Operating income		—			88			472			172		—			732
Other (income) expense, net		—			8			(1	)		7		—			14
Interest expense, net		—			12			229			28		—			269
Equity in net income of subsidiaries		(449	)		(341	)		—			—		790			—
Income (loss) before income taxes		449			409			244			137		(790	)		449
Income tax expense (benefit)		109			69			—			40		(109	)		109
Net income (loss)	$	340		$	340		$	244		$	97	$	(681	)	$	340
Currency translation		34			—			—			34		(34	)		34
Interest rate hedges		28			28			—			—		(28	)		28
Defined benefit pension and retiree health benefit plans		38			25			—			13		(38	)		38
Provision for income taxes related to other comprehensive income items		(20	)		(20	)		—			—		20			(20	)
Comprehensive income (loss)	$	420		$	373		$	244		$	144	$	(761	)	$	420

	Fiscal 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	599		$	4,220		$	1,670		$	—		$	6,489
Cost of goods sold		—			476			3,388			1,338			—			5,202
Selling, general and administrative		—			72			324			135			—			531
Amortization of intangibles		—			8			107			28			—			143
Restructuring and impairment charges		—			—			28			4			—			32
Operating income		—			43			373			165			—			581
Other (income) expense, net		—			15			(211	)		178			—			(18	)
Interest expense, net		—			36			205			50			—			291
Equity in net income of subsidiaries		(308	)		(279	)		—			—			587			—
Income (loss) before income taxes		308			271			379			(63	)		(587	)		308
Income tax expense (benefit)		72			34			8			29			(71	)		72
Net income (loss)	$	236		$	237		$	371		$	(92	)	$	(516	)	$	236
Currency translation		(1	)		—			—			(1	)		1			(1	)
Interest rate hedges		(14	)		(14	)		—			—			14			(14	)
Defined benefit pension and retiree health benefit plans		(23	)		(10	)		—			(13	)		23			(23	)
Provision for income taxes related to other comprehensive income items		9			9			—			—			(9	)		9
Comprehensive income (loss)	$	207		$	222		$	371		$	(106	)	$	(487	)	$	207

Condensed Supplemental Consolidated Balance Sheet

As of fiscal year end 2018

	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Assets
Current assets:
Cash and cash equivalents	$	—	$	133	$	4	$	244	$	—		$	381
Accounts receivable, net		—		42		555		344		—			941
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Inventories		—		56		664		167		—			887
Prepaid expenses and other current		—		18		17		41		—			76
Total current assets		296		2,156		1,240		845		(2,252	)		2,285
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Goodwill and intangible assets, net		—		79		3,742		463		—			4,284
Investment in subsidiaries		1,513		6,151		1,105		—		(8,769	)		—
Other assets		31		17		2		24		—			74
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131
Liabilities and equity
Current liabilities:
Accounts payable	$	—	$	42	$	468	$	273	$	—		$	783
Accrued expenses and other current liabilities		18		146		159		93		—			416
Intercompany payable		—		—		2,252		—		(2,252	)		—
Current portion of long-term debt		—		30		8		—		—			38
Total current liabilities		18		218		2,887		366		(2,252	)		1,237
Long-term debt, less current portion		—		5,782		23		1		—			5,806
Deferred income taxes		365		—		—		—		—			365
Other long-term liabilities		23		163		45		58		—			289
Total long-term liabilities		388		5,945		68		59		—			6,460
Total liabilities		406		6,163		2,955		425		(2,252	)		7,697

Total equity (deficit)		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and equity (deficit)	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Balance Sheet

As of fiscal year end 2017

	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Assets
Current assets:
Cash and cash equivalents	$	—	$	18	$	12	$	276	$	—		$	306
Accounts receivable, net		—		49		503		295		—			847
Intercompany receivable		512		2,217		—		—		(2,729	)		—
Inventories		—		42		567		153		—			762
Prepaid expenses and other current		—		7		31		51		—			89
Total current assets		512		2,333		1,113		775		(2,729	)		2,004
Property, plant and equipment, net		—		80		1,564		722		—			2,366
Goodwill and intangible assets, net		—		79		3,476		506		—			4,061
Investment in subsidiaries		992		5,240		1,105		—		(7,337	)		—
Other assets		—		16		2		27		—			45
Total assets	$	1,504	$	7,748	$	7,260	$	2,030	$	(10,066	)	$	8,476
Liabilities and equity
Current liabilities:
Accounts payable	$	—	$	43	$	356	$	239	$	—		$	638
Accrued expenses and other current liabilities		36		168		181		78		—			463
Intercompany payable		—		—		2,667		62		(2,729	)		—
Current portion of long-term debt		—		32		—		1		—			33
Total current liabilities		36		243		3,204		380		(2,729	)		1,134
Long-term debt, less current portion		—		5,579		29		—		—			5,608
Deferred income taxes		419		—		—		—		—			419
Other long-term liabilities		34		128		70		68		—			300
Total long-term liabilities		453		5,707		99		68		—			6,327
Total liabilities		489		5,950		3,303		448		(2,729	)		7,461
		—		—		—		—		—			—
Total equity (deficit)		1,015		1,798		3,957		1,582		(7,337	)		1,015
Total liabilities and equity (deficit)	$	1,504	$	7,748	$	7,260	$	2,030	$	(10,066	)	$	8,476

Condensed Supplemental Consolidated Statements of Cash Flows

	Fiscal 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	133		$	651		$	220		$	—		$	1,004

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(5	)		(241	)		(90	)		—			(336	)
Proceeds from sale of assets		—			—			3			—			—			3
(Contributions) distributions to/from subsidiaries		10			(715	)		—			—			705			—
Intercompany advances (repayments)		—			538			—			—			(538	)		—
Acquisition of business, net of cash acquired		—			—			(632	)		(70	)		—			(702	)
Net cash from investing activities		10			(182	)		(870	)		(160	)		167			(1,035	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			498			—			—			—			498
Repayment of long-term borrowings		—			(331	)		(3	)		(1	)		—			(335	)
Proceed from issuance of common stock		23			—			—			—			—			23
Repurchase of common stock		(33	)		—			—			—			—			(33	)
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Debt financing costs		—			(3	)		—			—			—			(3	)
Changes in intercompany balances		37			—			(418	)		(157	)		538			—
Contribution from Parent		—			—			632			73			(705	)		—
Net cash from financing activities		(10	)		164			211			(85	)		(167	)		113
Effect of currency translation on cash		—			—			—			(7	)		—			(7	)
Net change in cash and cash equivalents		—			115			(8	)		(32	)		—			75
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	133		$	4		$	244		$	—		$	381

	Fiscal 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	128		$	647		$	200		$	—		$	975

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(19	)		(209	)		(41	)		—			(269	)
Proceeds from sale of assets		—			1			5			—			—			6
(Contributions) distributions to/from subsidiaries		(31	)		(484	)		—			—			515			—
Intercompany advances (repayments)		—			428			—			—			(428	)		—
Acquisition of business, net of cash acquired		—			—			(515	)		—			—			(515	)
Other investing activities, net		—			4			—			—			—			4
Net cash from investing activities		(31	)		(70	)		(719	)		(41	)		87			(774	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			495			—			—			—			495
Repayment of long-term borrowings		—			(632	)		(3	)		(1	)		—			(636	)
Proceed from issuance of common stock		31			—			—			—			—			31
Payment of tax receivable agreement		(111	)		—			—			—			—			(111	)
Debt financing costs		—			(5	)		—			—			—			(5	)
Changes in intercompany balances		111			—			(433	)		(106	)		428			—
Contribution from Parent		—			—			515			—			(515	)		—
Net cash from financing activities		31			(142	)		79			(107	)		(87	)		(226	)
Effect of currency translation on cash		—			—			—			8			—			8
Net change in cash and cash equivalents		—			(84	)		7			60			—			(17	)
Cash and cash equivalents at beginning of period		—			102			5			216			—			323
Cash and cash equivalents at end of period	$	—		$	18		$	12		$	276		$	—		$	306

	Fiscal 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	103		$	566		$	188		$	—		$	857

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(13	)		(239	)		(36	)		—			(288	)
Proceeds from sale of assets		—			—			5			—			—			5
(Contributions) distributions to/from subsidiaries		(26	)		(2,234	)		—			—			2,260			—
Intercompany advances (repayments)		—			96			—			—			(96	)		—
Acquisition of business, net of cash acquired		—			—			(368	)		(1,915	)		—			(2,283	)
Other investing activities, net		—			(13	)		—			—			—			(13	)
Net cash from investing activities		(26	)		(2,164	)		(602	)		(1,951	)		2,164			(2,579	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			2,490			—			—			—			2,490
Repayment of long-term borrowings		—			(450	)		(23	)		(51	)		—			(524	)
Proceeds from issuance of common stock		26			—			—			—			—			26
Payment of tax receivable agreement		(57	)		—			—			—			—			(57	)
Debt financing costs		—			(40	)		—			—			—			(40	)
Purchase of non-controlling interest		—			—			(66	)		(12	)		—			(78	)
Changes in intercompany balances		57			—			(238	)		85			96			—
Contribution from Parent		—			—			368			1,892			(2,260	)		—
Net cash from financing activities		26			2,000			41			1,914			(2,164	)		1,817
Effect of currency translation on cash		—			—			—			—			—			—
Net change in cash and cash equivalents		—			(61	)		5			151			—			95
Cash and cash equivalents at beginning of period		—			163			—			65			—			228
Cash and cash equivalents at end of period	$	—		$	102		$	5		$	216		$	—		$	323

Basis of Presentation and Summary of Significant Accounting Policies (Policies)

12 Months Ended

Sep. 29, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Consolidation

Revenue Recognition

Purchases of Raw Materials and Concentration of Risk

Research and Development

Stock-Based Compensation

Share-Based Compensation

Foreign Currency

Cash and Cash Equivalents

All highly liquid investments purchased with a maturity of three months or less from the time of purchase are considered to be cash equivalents.

Allowance for Doubtful Accounts

	2018			2017			2016
Allowance for doubtful accounts, beginning	$	13		$	8		$	3
Acquisition allowance for doubtful accounts		2			5			6
Bad debt expense		1			1			1
Write-offs against allowance		(3	)		(1	)		(2	)
Allowance for doubtful accounts, ending	$	13		$	13		$	8

Accounts Receivable Factoring Agreements

Inventories

Inventories:	2018		2017
Finished goods	$	503	$	428
Raw materials		384		334
	$	887	$	762

Property, Plant and Equipment

Property, plant and equipment:	2018			2017
Land, buildings and improvements	$	875		$	792
Equipment and construction in progress		4,242			3,895
		5,117			4,687
Less accumulated depreciation		(2,629	)		(2,321	)
	$	2,488		$	2,366

Long-Lived Assets

Long-lived Assets

Goodwill

The changes in the carrying amount of goodwill by reportable segment are as follows:

	Consumer Packaging			Health, Hygiene & Specialties			Engineered Materials			Total
Balance as of fiscal 2016	$	1,520		$	801		$	85		$	2,406
Segment re-alignment		(110	)		7			103			—
Foreign currency translation adjustment		1			11			(1	)		11
Acquisitions, net		—			—			358			358
Balance as of fiscal 2017	$	1,411		$	819		$	545		$	2,775
Foreign currency translation adjustment		(2	)		(26	)		1			(27	)
Acquisitions, net		—			109			87			196
Balance as of fiscal 2018	$	1,409		$	902		$	633		$	2,944

Deferred Financing Fees

Intangible Assets

	Customer Relationships			Trademarks			Other Intangibles			Accumulated Amortization			Total
Balance as of fiscal 2016	$	1,690		$	326		$	182		$	(998	)	$	1,200
Adjustment for income taxes		—			1			—			—			1
Foreign currency translation adjustment		6			(1	)		1			(3	)		3
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		226			9			1			—			236
Balance as of fiscal 2017	$	1,922		$	335		$	184		$	(1,155	)	$	1,286

Foreign currency translation adjustment		(17	)		(1	)		(2	)		8			(12	)
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		177			9			34			—			220
Netting of fully amortized intangibles		(200	)		(50	)		(31	)		281			—
Balance as of fiscal 2018	$	1,882		$	293		$	185		$	(1,020	)	$	1,340

Insurable Liabilities

Income Taxes

Comprehensive Income (Loss)

The accumulated balances related to each component of other comprehensive income (loss) were as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance as of fiscal 2015	$	(81	)	$	(25	)	$	(13	)	$	(119	)
Other comprehensive loss		(1	)		(25	)		(30	)		(56	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			2			16			18
Provision for income taxes		—			4			5			9
Balance as of fiscal 2016	$	(82	)	$	(44	)	$	(22	)	$	(148	)
Other comprehensive income		34			25			7			66
Net amount reclassified from accumulated other comprehensive income (loss)		—			13			21			34
Provision for income taxes		—			(10	)		(10	)		(20	)
Balance as of fiscal 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss)		(127	)		9			46			(72	)
Net amount reclassified from accumulated other comprehensive income (loss) ^(a)		—			(6	)		3			(3	)
Provision for income taxes		—			—			(13	)		(13	)
Balance as of fiscal 2018	$	(175	)	$	(13	)	$	32		$	(156	)

(a)	See Note 4 for further discussion on amounts reclassified out of accumulated other comprehensive income (loss) related to interest rate swaps and Note 9 for amounts reclassified related to pensions.

Recently Issued Accounting Pronouncements

Revenue Recognition

Leases

Retirement Benefits

Hedges

Fair Value

Defined Benefit Plans

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Sep. 29, 2018

Basis of Presentation and Summary of Significant Accounting Policies [Abstract]

Allowance for Doubtful Accounts

The following table summarizes the activity for fiscal years ended for the allowance for doubtful accounts:

	2018			2017			2016
Allowance for doubtful accounts, beginning	$	13		$	8		$	3
Acquisition allowance for doubtful accounts		2			5			6
Bad debt expense		1			1			1
Write-offs against allowance		(3	)		(1	)		(2	)
Allowance for doubtful accounts, ending	$	13		$	13		$	8

Inventories

Inventory as of fiscal 2018 and 2017 was:

Inventories:	2018		2017
Finished goods	$	503	$	428
Raw materials		384		334
	$	887	$	762

Property, Plant and Equipment

Property, plant and equipment as of fiscal 2018 and 2017 was:

Property, plant and equipment:	2018			2017
Land, buildings and improvements	$	875		$	792
Equipment and construction in progress		4,242			3,895
		5,117			4,687
Less accumulated depreciation		(2,629	)		(2,321	)
	$	2,488		$	2,366

Goodwill

The changes in the carrying amount of goodwill by reportable segment are as follows:

	Consumer Packaging			Health, Hygiene & Specialties			Engineered Materials			Total
Balance as of fiscal 2016	$	1,520		$	801		$	85		$	2,406
Segment re-alignment		(110	)		7			103			—
Foreign currency translation adjustment		1			11			(1	)		11
Acquisitions, net		—			—			358			358
Balance as of fiscal 2017	$	1,411		$	819		$	545		$	2,775
Foreign currency translation adjustment		(2	)		(26	)		1			(27	)
Acquisitions, net		—			109			87			196
Balance as of fiscal 2018	$	1,409		$	902		$	633		$	2,944

Intangible Assets

	Customer Relationships			Trademarks			Other Intangibles			Accumulated Amortization			Total
Balance as of fiscal 2016	$	1,690		$	326		$	182		$	(998	)	$	1,200
Adjustment for income taxes		—			1			—			—			1
Foreign currency translation adjustment		6			(1	)		1			(3	)		3
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		226			9			1			—			236
Balance as of fiscal 2017	$	1,922		$	335		$	184		$	(1,155	)	$	1,286

Foreign currency translation adjustment		(17	)		(1	)		(2	)		8			(12	)
Amortization expense		—			—			—			(154	)		(154	)
Acquisition intangibles		177			9			34			—			220
Netting of fully amortized intangibles		(200	)		(50	)		(31	)		281			—
Balance as of fiscal 2018	$	1,882		$	293		$	185		$	(1,020	)	$	1,340

Accumulated Other Comprehensive Income (Loss)

The accumulated balances related to each component of other comprehensive income (loss) were as follows:

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance as of fiscal 2015	$	(81	)	$	(25	)	$	(13	)	$	(119	)
Other comprehensive loss		(1	)		(25	)		(30	)		(56	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			2			16			18
Provision for income taxes		—			4			5			9
Balance as of fiscal 2016	$	(82	)	$	(44	)	$	(22	)	$	(148	)
Other comprehensive income		34			25			7			66
Net amount reclassified from accumulated other comprehensive income (loss)		—			13			21			34
Provision for income taxes		—			(10	)		(10	)		(20	)
Balance as of fiscal 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss)		(127	)		9			46			(72	)
Net amount reclassified from accumulated other comprehensive income (loss) ^(a)		—			(6	)		3			(3	)
Provision for income taxes		—			—			(13	)		(13	)
Balance as of fiscal 2018	$	(175	)	$	(13	)	$	32		$	(156	)

(a)	See Note 4 for further discussion on amounts reclassified out of accumulated other comprehensive income (loss) related to interest rate swaps and Note 9 for amounts reclassified related to pensions.

Long-Term Debt (Tables)

12 Months Ended

Sep. 29, 2018

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	September 29, 2018			September 30, 2017
Term loan	February 2020	$	800		$	1,000
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,645
Term loan	January 2024		493			498
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			—
Debt discounts and deferred fees			(43	)		(48	)
Capital leases and other	Various		135			132
Total long-term debt			5,844			5,641
Current portion of long-term debt			(38	)		(33	)
Long-term debt, less current portion		$	5,806		$	5,608

Future Maturities of Long-Term Debt

Future maturities of long-term debt as of fiscal year end 2018 are as follows:

Fiscal Year	Maturities
2019	$	38
2020		837
2021		842
2022		27
2023		2,458
Thereafter		1,685
	$	5,887

Financial Instruments and Fair Value Measurements (Tables)

12 Months Ended

Sep. 29, 2018

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

Derivatives Instruments	Hedge Designation	Balance Sheet Location	2018		2017
Cross-currency swaps	Designated	Other long-term liabilities	$	11	$	—
Interest rate swaps	Designated	Other assets		16		1
Interest rate swaps	Not designated	Other assets		—		13
Interest rate swaps	Designated	Other long-term liabilities		—		15
Interest rate swaps	Not designated	Other long-term liabilities		1		13

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows:

		Fiscal years ended
Derivatives instruments	Statement of Income Location	September 29, 2018			September 30, 2017			October 1, 2016
Cross-currency swaps	Interest expense, net	$	(5	)	$	—		$	—
Foreign currency swaps	Other (income) expense		—			(2	)		13
Interest rate swaps	Interest expense, net	$	(1	)	$	24		$	16

Assets Measured at Fair Value on Non-recurring Basis

	As of the end of fiscal 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	—

	As of the end of fiscal 2017
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,775		2,775		—
Definite lived intangible assets		—		—		1,038		1,038		—
Property, plant and equipment		—		—		2,366		2,366		2
Total	$	—	$	—	$	6,427	$	6,427	$	2

	As of the end of fiscal 2016
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,406		2,406		—
Definite lived intangible assets		—		—		952		952		—
Property, plant and equipment		—		—		2,224		2,224		3
Total	$	—	$	—	$	5,830	$	5,830	$	3

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

12 Months Ended

Sep. 29, 2018

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities as of fiscal year end.

	2018		2017
Employee compensation, payroll, and other	$	113	$	147
Accrued taxes		72		90
Rebates		58		58
Interest		49		36
Tax receivable agreement obligation		16		35
Restructuring		13		19
Other		95		78
	$	416	$	463

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities as of fiscal year end.

	2018		2017
Lease retirement obligation	$	39	$	37
Uncertain tax positions		74		59
Pension liability		45		56
Deferred purchase price		40		46
Tax receivable agreement obligation		23		34
Sale-lease back deferred gain		21		24
Transition tax		18		—
Derivative instruments		12		27
Other		17		17
	$	289	$	300

Income Taxes (Tables)

12 Months Ended

Sep. 29, 2018

Income Taxes [Abstract]

Components of Income Tax Expense

Significant components of income tax expense for the fiscal years ended are as follows:

	2018			2017			2016
Current
U.S.
Federal	$	19		$	40		$	—
State		8			6			5
Non-U.S.		40			58			36
Total current		67			104			41
Deferred:
U.S.
Federal		(72	)		34			35
State		12			(10	)		3
Non-U.S.		(26	)		(19	)		(7	)
Total deferred		(86	)		5			31
Expense for income taxes	$	(19	)	$	109		$	72

Effective Income Tax Rate Reconciliation

The reconciliation between U.S. Federal income taxes at the statutory rate and the Company’s benefit for income taxes on continuing operations for fiscal year end is follows:

	2018			2017			2016
U.S. Federal income tax expense at the statutory rate	$	117		$	157		$	108
Adjustments to reconcile to the income tax provision:
U.S. state income tax expense		12			6			8
Changes in state valuation allowance		—			(9	)		2
Research and development credits		(7	)		(7	)		(8	)
Share-based compensation		(8	)		(33	)		(15	)
U.S. tax reform		(124	)		—			—
Permanent differences		—			2			2
Changes in foreign valuation allowance		(10	)		3			(1	)
Foreign income taxed in the U.S.		—			—			7
Manufacturing tax benefits		(6	)		(6	)		—
Deduction of worthless investment		—			—			(9	)
Permanent foreign currency differences		—			(1	)		(8	)
Rate differences between U.S. and foreign		3			(11	)		(14	)
Other		4			8			—
Expense for income taxes	$	(19	)	$	109		$	72

Net Deferred Income Tax Liability

The components of the net deferred income tax liability as of fiscal year end are as follows:

	2018			2017
Deferred tax assets:
Allowance for doubtful accounts	$	4		$	7
Deferred gain on sale-leaseback		6			10
Accrued liabilities and reserves		28			89
Inventories		9			6
Net operating loss carryforward		212			292
Alternative minimum tax (AMT) credit carryforward		8			11
Research and development credit carryforward		13			18
Federal and state tax credits		10			9
Other		19			14
Total deferred tax assets		309			456
Valuation allowance		(93	)		(93	)
Total deferred tax assets, net of valuation allowance		216			363
Deferred tax liabilities:
Property, plant and equipment		239			277
Intangible assets		306			475
Debt extinguishment		—			27
Other		5			3
Total deferred tax liabilities		550			782
Net deferred tax liability	$	(334	)	$	(419	)

Gross Unrecognized Tax Benefits

The following table summarizes the activity related to our gross unrecognized tax benefits for fiscal year end:

	2018			2017
Beginning unrecognized tax benefits	$	59		$	62
Gross increases – tax positions in prior periods		1			1
Gross increases – current period tax positions		19			4
Gross decreases – tax positions in prior periods		—			(1	)
Settlements		—			(3	)
Lapse of statute of limitations		(5	)		(4	)
Ending unrecognized tax benefits	$	74		$	59

Retirement Plans (Tables)

12 Months Ended

Sep. 29, 2018

Retirement Plans [Abstract]

Change in Projected Benefit Obligations and Fair Value of Plan Assets

The net amount of liability recognized is included in Other long-term liabilities on the Consolidated Balance Sheets.

	Defined Benefit Pension Plans						Retiree Health Plans
	2018			2017			2018			2017
Change in Projected Benefit Obligations (PBO)

PBO at beginning of period	$	330		$	492		$	7		$	7
Interest cost		11			11			—			—
Actuarial loss (gain)		(17	)		(15	)		—			—
Plan conversion ^(a)		—			(139	)		—			—
Benefit settlements		—			(3	)		—			—
Benefits paid		(17	)		(16	)		(1	)		—
PBO at end of period	$	307		$	330		$	6		$	7

Change in Fair Value of Plan Assets

Plan assets at beginning of period	$	291		$	418		$	—		$	—
Actual return on plan assets		3			22			—			—
Company contributions		—			7			1			1
Plan conversion ^(a)		—			(136	)		—			—
Benefit settlements		—			(2	)		—			—
Benefits paid		(17	)		(18	)		(1	)		(1	)
Plan assets at end of period		277			291			—			—
Net amount recognized	$	(30	)	$	(39	)	$	(6	)	$	(7	)

(a)

Weighted-Average Assumptions Used to Determine Benefit Obligation and Benefit Cost

The following table presents significant weighted-average assumptions used to determine benefit obligation and benefit cost for the fiscal years ended:

	Defined Benefit Pension Plans				Retiree Health Plan
(Percentages)	2018		2017		2018		2017
Weighted-average assumptions:
Discount rate for benefit obligation		4.0		3.5		3.8		3.3
Discount rate for net benefit cost		3.5		3.2		3.3		2.9
Expected return on plan assets for net benefit costs		6.1		6.4		—		—

Fair Value of Plan Assets

Fiscal 2018 Asset Category	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	6	$	—	$	—	$	6
U.S. large cap comingled equity funds		—		67		—		67
U.S. mid cap equity mutual funds		50		—		—		50
U.S. small cap equity mutual funds		3		—		—		3
International equity mutual funds		15		—		—		15
Real estate equity investment funds		3		—		—		3
Corporate bond mutual funds		11		—		—		11
Corporate bonds		—		108		—		108
Guaranteed investment account		—		—		8		8
International fixed income funds		6		—		—		6
Total	$	94	$	175	$	8	$	277

Fiscal 2017 Asset Category	Level 1		Level 2		Level 3		Total
Cash and cash equivalents	$	6	$	—	$	—	$	6
U.S. large cap comingled equity funds		—		61		—		61
U.S. mid cap equity mutual funds		57		—		—		57
U.S. small cap equity mutual funds		3		—		—		3
International equity mutual funds		14		—		—		14
Real estate equity investment funds		4		—		—		4
Corporate bond mutual funds		17		—		—		17
Corporate bonds		—		114		—		114
Guaranteed investment account		—		—		9		9
International fixed income funds		6		—		—		6
Total	$	107	$	175	$	9	$	291

Expected Future Benefit Payments

The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid for the fiscal year end:

	Defined Benefit Pension Plans		Retiree Health Plan
2019	$	18	$	1
2020		18		1
2021		19		1
2022		19		—
2023		19		—
2024-2028		96		2

Net Pension and Retiree Health Benefit Expense

Net pension and retiree health benefit expense included the following components as of fiscal year end:

	2018			2017			2016
Service cost	$	—		$	—		$	3
Interest cost		11			11			16
Amortization of net actuarial loss		2			3			2
Expected return on plan assets		(17	)		(17	)		(20	)
Net periodic benefit cost	$	(4	)	$	(3	)	$	1

Plan Asset Allocations

Our defined benefit pension plan asset allocations as of fiscal year end are as follows:

	2018			2017
Asset Category
Equity securities and equity-like instruments		50	%		48	%
Debt securities and debt-like		45			47
Other		5			5
Total		100	%		100	%

Restructuring and Impairment Charges (Tables)

12 Months Ended

Sep. 29, 2018

Restructuring and Impairment Charges [Abstract]

Restructuring Charges

Since 2016, total expected costs attributed to restructuring programs total $95 million with $3 million remaining to be recognized in the future.

	Expected Total Costs		Cumulative Charges through Fiscal 2018		To be Recognized in Future
Severance and termination benefits	$	75	$	75	$	—
Facility exit costs		15		12		3
Asset impairment		5		5		—
Total	$	95	$	92	$	3

The tables below sets forth the significant components of the restructuring charges recognized for the fiscal years ended, by segment:

	2018		2017		2016
Engineered Materials	$	6	$	5	$	3
Health, Hygiene & Specialties		27		11		20
Consumer Packaging		3		8		9
Consolidated	$	36	$	24	$	32

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring charges and the impact on our accrued restructuring reserves:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance as of fiscal 2016	$	7		$	6		$	—		$	13
Acquisition		13			—			—			13
Charges		18			4			2			24
Non-cash asset impairment		—			—			(2	)		(2	)
Cash payments		(24	)		(5	)		—			(29	)
Balance as of fiscal 2017	$	14		$	5		$	—		$	19
Charges		34			2			—			36
Cash payments		(39	)		(3	)		—			(42	)
Balance as of fiscal 2018	$	9		$	4		$	—		$	13

Stockholders' Equity (Tables)

12 Months Ended

Sep. 29, 2018

Stockholders' Equity [Abstract]

Stock Option Activity

Information related to the equity incentive plans as of the fiscal year end is as follows:

	2018					2017
	Number of Shares (in thousands)			Weighted Average Exercise Price		Number of Shares (in thousands)			Weighted Average Exercise Price
Options outstanding, beginning of period		10,760		$	28.18		11,716		$	21.44
Options granted		1,453			54.33		1,820			49.53
Options exercised		(1,176	)		18.62		(2,562	)		12.07
Options forfeited or cancelled		(293	)		41.30		(214	)		33.52
Options outstanding, end of period		10,744		$	32.40		10,760		$	28.18

Option price range at end of period	$	3.04-54.33				$	3.04-49.53
Options exercisable at end of period		5,154					4,108
Options available for grant at period end		6,422					2,875
Weighted average fair value of options granted during period	$	17.84				$	15.52

Valuation Assumptions Used for Options Granted

The fair value for options granted has been estimated at the date of grant using a Black-Scholes model, generally with the following weighted average assumptions:

	2018			2017			2016
Risk-free interest rate		2.7	%		2.2	%		1.2	%
Dividend yield		0.0	%		0.0	%		0.0	%
Volatility factor		26.1	%		26.0	%		25.7	%
Expected option life	6.5 years			6.5 years			6.5 years

Options Outstanding

The following table summarizes information about the options outstanding as of fiscal 2018:

Range of Exercise Prices				Number Outstanding (in thousands)				Intrinsic Value of Outstanding (in millions)			Weighted Remaining Contractual Life		Weighted Exercise Price				Number Exercisable (in thousands)				Intrinsic Value of Exercisable (in millions)				Unrecognized Compensation (in millions)			Weighted Recognition Period
$	3.04-54.33				10,744			$	172		6.5 years		$	32.40				5,154			$	120			$	25		1.9 years

Segment and Geographic Data (Tables)

12 Months Ended

Sep. 29, 2018

Segment and Geographic Data [Abstract]

Selected Information by Reportable Segment

Selected information by reportable segment is presented in the following tables:

	2018		2017		2016
Net sales
Engineered Materials	$	2,672	$	2,375	$	1,627
Health, Hygiene & Specialties		2,734		2,369		2,400
Consumer Packaging		2,463		2,351		2,462
Total	$	7,869	$	7,095	$	6,489

Operating income
Engineered Materials	$	368	$	316	$	182
Health, Hygiene & Specialties		202		216		196
Consumer Packaging		191		200		203
Total	$	761	$	732	$	581

Depreciation and amortization
Engineered Materials	$	109	$	106	$	82
Health, Hygiene & Specialties		200		184		199
Consumer Packaging		229		231		244
Total	$	538	$	521	$	525

	2018		2017
Total assets:
Engineered Materials	$	1,998	$	1,803
Health, Hygiene & Specialties		3,913		3,496
Consumer Packaging		3,220		3,177
Total assets	$	9,131	$	8,476
Goodwill:
Engineered Materials	$	633	$	545
Health, Hygiene & Specialties		902		819
Consumer Packaging		1,409		1,411
Total goodwill	$	2,944	$	2,775

Selected Information by Geography

Selected information by geography is presented in the following tables:

	2018		2017		2016
Net sales:
North America	$	6,474	$	5,850	$	5,250
South America		332		333		336
Europe		807		646		661
Asia		256		266		242
Total net sales	$	7,869	$	7,095	$	6,489

	2018		2017
Long-lived assets:
North America	$	5,764	$	5,303
South America		320		418
Europe		463		467
Asia		299		284
Total Long-lived assets	$	6,846	$	6,472

Selected Information by Product Line

Selected information by product line is presented in the following tables:

(in percentages)	2018			2017			2016
Net sales:
Core Films		46	%		49	%		72	%
Retail & Industrial		54			51			28
Engineered Materials		100	%		100	%		100	%

Health		19	%		22	%		20	%
Hygiene		43			44			45
Specialties		38			34			35
Health, Hygiene & Specialties		100	%		100	%		100	%

Rigid Open Top		44	%		43	%		42	%
Rigid Closed Top		56			57			58
Consumer Packaging		100	%		100	%		100	%

Guarantor and Non-Guarantor Financial Information (Tables)

12 Months Ended

Sep. 29, 2018

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Statements of Operations

	Fiscal 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	574		$	5,465		$	1,830		$	—		$	7,869
Cost of goods sold		—			346			4,558			1,534			—			6,438
Selling, general and administrative		—			63			309			108			—			480
Amortization of intangibles		—			1			127			26			—			154
Restructuring and impairment charges		—			—			20			16			—			36
Operating income		—			164			451			146			—			761
Other (income) expense, net		—			8			8			9			—			25
Interest expense, net		—			8			225			26			—			259
Equity in net income of subsidiaries		(477	)		(307	)		—			—			784			—
Income (loss) before income taxes		477			455			218			111			(784	)		477
Income tax expense (benefit)		(19	)		(41	)		(2	)		24			19			(19	)
Net income (loss)	$	496		$	496		$	220		$	87		$	(803	)	$	496
Currency translation		(127	)		(11	)		(3	)		(113	)		127			(127	)
Interest rate hedges		49			49			—			—			(49	)		49
Defined benefit pension and retiree health benefit plans		3			—			—			3			(3	)		3
Provision for income taxes related to other comprehensive income items		(13	)		(13	)		—			—			13			(13	)
Comprehensive income (loss)	$	408		$	521		$	217		$	(23	)	$	(715	)	$	408

	Fiscal 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	587		$	4,861		$	1,647	$	—		$	7,095
Cost of goods sold		—			438			3,920			1,333		—			5,691
Selling, general and administrative		—			55			335			104		—			494
Amortization of intangibles		—			6			120			28		—			154
Restructuring and impairment charges		—			—			14			10		—			24
Operating income		—			88			472			172		—			732
Other (income) expense, net		—			8			(1	)		7		—			14
Interest expense, net		—			12			229			28		—			269
Equity in net income of subsidiaries		(449	)		(341	)		—			—		790			—
Income (loss) before income taxes		449			409			244			137		(790	)		449
Income tax expense (benefit)		109			69			—			40		(109	)		109
Net income (loss)	$	340		$	340		$	244		$	97	$	(681	)	$	340
Currency translation		34			—			—			34		(34	)		34
Interest rate hedges		28			28			—			—		(28	)		28
Defined benefit pension and retiree health benefit plans		38			25			—			13		(38	)		38
Provision for income taxes related to other comprehensive income items		(20	)		(20	)		—			—		20			(20	)
Comprehensive income (loss)	$	420		$	373		$	244		$	144	$	(761	)	$	420

	Fiscal 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	599		$	4,220		$	1,670		$	—		$	6,489
Cost of goods sold		—			476			3,388			1,338			—			5,202
Selling, general and administrative		—			72			324			135			—			531
Amortization of intangibles		—			8			107			28			—			143
Restructuring and impairment charges		—			—			28			4			—			32
Operating income		—			43			373			165			—			581
Other (income) expense, net		—			15			(211	)		178			—			(18	)
Interest expense, net		—			36			205			50			—			291
Equity in net income of subsidiaries		(308	)		(279	)		—			—			587			—
Income (loss) before income taxes		308			271			379			(63	)		(587	)		308
Income tax expense (benefit)		72			34			8			29			(71	)		72
Net income (loss)	$	236		$	237		$	371		$	(92	)	$	(516	)	$	236
Currency translation		(1	)		—			—			(1	)		1			(1	)
Interest rate hedges		(14	)		(14	)		—			—			14			(14	)
Defined benefit pension and retiree health benefit plans		(23	)		(10	)		—			(13	)		23			(23	)
Provision for income taxes related to other comprehensive income items		9			9			—			—			(9	)		9
Comprehensive income (loss)	$	207		$	222		$	371		$	(106	)	$	(487	)	$	207

Condensed Supplemental Consolidated Balance Sheet

As of fiscal year end 2018

	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Assets
Current assets:
Cash and cash equivalents	$	—	$	133	$	4	$	244	$	—		$	381
Accounts receivable, net		—		42		555		344		—			941
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Inventories		—		56		664		167		—			887
Prepaid expenses and other current		—		18		17		41		—			76
Total current assets		296		2,156		1,240		845		(2,252	)		2,285
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Goodwill and intangible assets, net		—		79		3,742		463		—			4,284
Investment in subsidiaries		1,513		6,151		1,105		—		(8,769	)		—
Other assets		31		17		2		24		—			74
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131
Liabilities and equity
Current liabilities:
Accounts payable	$	—	$	42	$	468	$	273	$	—		$	783
Accrued expenses and other current liabilities		18		146		159		93		—			416
Intercompany payable		—		—		2,252		—		(2,252	)		—
Current portion of long-term debt		—		30		8		—		—			38
Total current liabilities		18		218		2,887		366		(2,252	)		1,237
Long-term debt, less current portion		—		5,782		23		1		—			5,806
Deferred income taxes		365		—		—		—		—			365
Other long-term liabilities		23		163		45		58		—			289
Total long-term liabilities		388		5,945		68		59		—			6,460
Total liabilities		406		6,163		2,955		425		(2,252	)		7,697

Total equity (deficit)		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and equity (deficit)	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Balance Sheet

As of fiscal year end 2017

	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Assets
Current assets:
Cash and cash equivalents	$	—	$	18	$	12	$	276	$	—		$	306
Accounts receivable, net		—		49		503		295		—			847
Intercompany receivable		512		2,217		—		—		(2,729	)		—
Inventories		—		42		567		153		—			762
Prepaid expenses and other current		—		7		31		51		—			89
Total current assets		512		2,333		1,113		775		(2,729	)		2,004
Property, plant and equipment, net		—		80		1,564		722		—			2,366
Goodwill and intangible assets, net		—		79		3,476		506		—			4,061
Investment in subsidiaries		992		5,240		1,105		—		(7,337	)		—
Other assets		—		16		2		27		—			45
Total assets	$	1,504	$	7,748	$	7,260	$	2,030	$	(10,066	)	$	8,476
Liabilities and equity
Current liabilities:
Accounts payable	$	—	$	43	$	356	$	239	$	—		$	638
Accrued expenses and other current liabilities		36		168		181		78		—			463
Intercompany payable		—		—		2,667		62		(2,729	)		—
Current portion of long-term debt		—		32		—		1		—			33
Total current liabilities		36		243		3,204		380		(2,729	)		1,134
Long-term debt, less current portion		—		5,579		29		—		—			5,608
Deferred income taxes		419		—		—		—		—			419
Other long-term liabilities		34		128		70		68		—			300
Total long-term liabilities		453		5,707		99		68		—			6,327
Total liabilities		489		5,950		3,303		448		(2,729	)		7,461
		—		—		—		—		—			—
Total equity (deficit)		1,015		1,798		3,957		1,582		(7,337	)		1,015
Total liabilities and equity (deficit)	$	1,504	$	7,748	$	7,260	$	2,030	$	(10,066	)	$	8,476

Condensed Supplemental Consolidated Statements of Cash Flows

	Fiscal 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	133		$	651		$	220		$	—		$	1,004

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(5	)		(241	)		(90	)		—			(336	)
Proceeds from sale of assets		—			—			3			—			—			3
(Contributions) distributions to/from subsidiaries		10			(715	)		—			—			705			—
Intercompany advances (repayments)		—			538			—			—			(538	)		—
Acquisition of business, net of cash acquired		—			—			(632	)		(70	)		—			(702	)
Net cash from investing activities		10			(182	)		(870	)		(160	)		167			(1,035	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			498			—			—			—			498
Repayment of long-term borrowings		—			(331	)		(3	)		(1	)		—			(335	)
Proceed from issuance of common stock		23			—			—			—			—			23
Repurchase of common stock		(33	)		—			—			—			—			(33	)
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Debt financing costs		—			(3	)		—			—			—			(3	)
Changes in intercompany balances		37			—			(418	)		(157	)		538			—
Contribution from Parent		—			—			632			73			(705	)		—
Net cash from financing activities		(10	)		164			211			(85	)		(167	)		113
Effect of currency translation on cash		—			—			—			(7	)		—			(7	)
Net change in cash and cash equivalents		—			115			(8	)		(32	)		—			75
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	133		$	4		$	244		$	—		$	381

	Fiscal 2017
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	128		$	647		$	200		$	—		$	975

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(19	)		(209	)		(41	)		—			(269	)
Proceeds from sale of assets		—			1			5			—			—			6
(Contributions) distributions to/from subsidiaries		(31	)		(484	)		—			—			515			—
Intercompany advances (repayments)		—			428			—			—			(428	)		—
Acquisition of business, net of cash acquired		—			—			(515	)		—			—			(515	)
Other investing activities, net		—			4			—			—			—			4
Net cash from investing activities		(31	)		(70	)		(719	)		(41	)		87			(774	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			495			—			—			—			495
Repayment of long-term borrowings		—			(632	)		(3	)		(1	)		—			(636	)
Proceed from issuance of common stock		31			—			—			—			—			31
Payment of tax receivable agreement		(111	)		—			—			—			—			(111	)
Debt financing costs		—			(5	)		—			—			—			(5	)
Changes in intercompany balances		111			—			(433	)		(106	)		428			—
Contribution from Parent		—			—			515			—			(515	)		—
Net cash from financing activities		31			(142	)		79			(107	)		(87	)		(226	)
Effect of currency translation on cash		—			—			—			8			—			8
Net change in cash and cash equivalents		—			(84	)		7			60			—			(17	)
Cash and cash equivalents at beginning of period		—			102			5			216			—			323
Cash and cash equivalents at end of period	$	—		$	18		$	12		$	276		$	—		$	306

	Fiscal 2016
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	103		$	566		$	188		$	—		$	857

Cash Flow from Investing Activities
Additions to property, plant and equipment		—			(13	)		(239	)		(36	)		—			(288	)
Proceeds from sale of assets		—			—			5			—			—			5
(Contributions) distributions to/from subsidiaries		(26	)		(2,234	)		—			—			2,260			—
Intercompany advances (repayments)		—			96			—			—			(96	)		—
Acquisition of business, net of cash acquired		—			—			(368	)		(1,915	)		—			(2,283	)
Other investing activities, net		—			(13	)		—			—			—			(13	)
Net cash from investing activities		(26	)		(2,164	)		(602	)		(1,951	)		2,164			(2,579	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			2,490			—			—			—			2,490
Repayment of long-term borrowings		—			(450	)		(23	)		(51	)		—			(524	)
Proceeds from issuance of common stock		26			—			—			—			—			26
Payment of tax receivable agreement		(57	)		—			—			—			—			(57	)
Debt financing costs		—			(40	)		—			—			—			(40	)
Purchase of non-controlling interest		—			—			(66	)		(12	)		—			(78	)
Changes in intercompany balances		57			—			(238	)		85			96			—
Contribution from Parent		—			—			368			1,892			(2,260	)		—
Net cash from financing activities		26			2,000			41			1,914			(2,164	)		1,817
Effect of currency translation on cash		—			—			—			—			—			—
Net change in cash and cash equivalents		—			(61	)		5			151			—			95
Cash and cash equivalents at beginning of period		—			163			—			65			—			228
Cash and cash equivalents at end of period	$	—		$	102		$	5		$	216		$	—		$	323

Basis of Presentation and Summary of Significant Accounting Policies, Purchases of Raw Materials and Concentration of Risk (Details)	12 Months Ended
	Sep. 29, 2018
Purchases of Raw Materials [Member] \| Supplier Concentration Risk [Member]
Purchases of Raw Materials and Concentration of Risk [Abstract]
Concentration risk percentage	16.00%

Basis of Presentation and Summary of Significant Accounting Policies, Allowance for Doubtful Accounts (Details) - Allowance for Doubtful Accounts [Member] - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Movement in Valuation Allowance [Roll Forward]
Allowance for doubtful accounts, beginning	$ 13	$ 8	$ 3
Acquisition allowance for doubtful accounts	2	5	6
Bad debt expense	1	1	1
Write-offs against allowance	(3)	(1)	(2)
Allowance for doubtful accounts, ending	$ 13	$ 13	$ 8

Basis of Presentation and Summary of Significant Accounting Policies, Inventories (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Inventories [Abstract]
Finished goods	$ 503	$ 428
Raw materials	384	334
Inventory, total	$ 887	$ 762

Basis of Presentation and Summary of Significant Accounting Policies, Property, Plant and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Property, plant and equipment [Abstract]
Capitalized interest	$ 9	$ 7	$ 6
Property, plant and equipment	5,117	4,687
Less accumulated depreciation	(2,629)	(2,321)
Property, plant and equipment, net	$ 2,488	2,366
Buildings and Improvements [Member] \| Minimum [Member]
Property, plant and equipment [Abstract]
Useful life	15 years
Buildings and Improvements [Member] \| Maximum [Member]
Property, plant and equipment [Abstract]
Useful life	40 years
Machinery, Equipment, and Tooling [Member] \| Minimum [Member]
Property, plant and equipment [Abstract]
Useful life	2 years
Machinery, Equipment, and Tooling [Member] \| Maximum [Member]
Property, plant and equipment [Abstract]
Useful life	20 years
Land, Buildings and Improvements [Member]
Property, plant and equipment [Abstract]
Property, plant and equipment	$ 875	792
Equipment and Construction In Progress [Member]
Property, plant and equipment [Abstract]
Property, plant and equipment	$ 4,242	$ 3,895

Basis of Presentation and Summary of Significant Accounting Policies, Goodwill (Details) $ in Millions	12 Months Ended
	Sep. 29, 2018 USD ($) ReportingUnit Region	Sep. 30, 2017 USD ($)	Oct. 01, 2016 USD ($)	Oct. 01, 2011 USD ($)
Goodwill [Abstract]
Number of reporting units \| ReportingUnit	7
Number of reporting units where components are aggregated to test goodwill \| ReportingUnit	3
Impairment charges	$ 0	$ 0	$ 0	$ 165
Goodwill [Roll Forward]
Goodwill, beginning balance	2,775	2,406
Segment re-alignment		0
Foreign currency translation adjustment	(27)	11
Acquisitions, net	196	358
Goodwill, ending balance	2,944	2,775	2,406
Consumer Packaging [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	1,411	1,520
Segment re-alignment		(110)
Foreign currency translation adjustment	(2)	1
Acquisitions, net	0	0
Goodwill, ending balance	$ 1,409	1,411	1,520
Health, Hygiene & Specialties [Member]
Goodwill [Abstract]
Number of geographical regions \| Region	4
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 819	801
Segment re-alignment		7
Foreign currency translation adjustment	(26)	11
Acquisitions, net	109	0
Goodwill, ending balance	$ 902	$ 819	801
Health, Hygiene & Specialties [Member] \| South America [Member]
Goodwill [Abstract]
Percentage of fair value in excess of carrying value	11.00%	9.00%
Impairment charges	$ 0	$ 0
Health, Hygiene & Specialties [Member] \| Asia [Member]
Goodwill [Abstract]
Percentage of fair value in excess of carrying value		49.00%
Impairment charges		$ 0
Engineered Materials [Member]
Goodwill [Roll Forward]
Goodwill, beginning balance	545	85
Segment re-alignment		103
Foreign currency translation adjustment	1	(1)
Acquisitions, net	87	358
Goodwill, ending balance	$ 633	$ 545	$ 85

Basis of Presentation and Summary of Significant Accounting Policies, Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Intangible Assets [Roll Forward]
Intangible assets, net, beginning balance	$ 1,286	$ 1,200
Adjustment for income taxes		1
Foreign currency translation adjustment	(12)	3
Acquisition intangibles	220	236
Netting of fully amortized intangibles	0
Intangible assets, net, ending balance	1,340	1,286	$ 1,200
Accumulated amortization, beginning balance	(1,155)	(998)
Foreign currency translation adjustment	8	(3)
Amortization expense	(154)	(154)	(143)
Netting of fully amortized intangibles	281
Accumulated amortization, ending balance	(1,020)	(1,155)	(998)
Customer Relationships [Member]
Intangible Assets [Roll Forward]
Intangible assets, beginning balance	1,922	1,690
Adjustment for income taxes		0
Foreign currency translation adjustment	(17)	6
Acquisition intangibles	177	226
Netting of fully amortized intangibles	(200)
Intangible assets, ending balance	$ 1,882	1,922	1,690
Customer Relationships [Member] \| Minimum [Member]
Intangible Assets [Abstract]
Useful life	5 years
Customer Relationships [Member] \| Maximum [Member]
Intangible Assets [Abstract]
Useful life	15 years
Trademarks [Member]
Intangible Assets [Abstract]
Indefinite lived intangible assets	$ 248	248
Intangible Assets [Roll Forward]
Intangible assets, beginning balance	335	326
Adjustment for income taxes		1
Foreign currency translation adjustment	(1)	(1)
Acquisition intangibles	9	9
Netting of fully amortized intangibles	(50)
Intangible assets, ending balance	$ 293	335	326
Trademarks [Member] \| Maximum [Member]
Intangible Assets [Abstract]
Useful life	15 years
Other Intangibles [Member]
Intangible Assets [Roll Forward]
Intangible assets, beginning balance	$ 184	182
Adjustment for income taxes		0
Foreign currency translation adjustment	(2)	1
Acquisition intangibles	34	1
Netting of fully amortized intangibles	(31)
Intangible assets, ending balance	$ 185	$ 184	$ 182
Other Intangibles [Member] \| Minimum [Member]
Intangible Assets [Abstract]
Useful life	5 years
Other Intangibles [Member] \| Maximum [Member]
Intangible Assets [Abstract]
Useful life	14 years

Basis of Presentation and Summary of Significant Accounting Policies, Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions

12 Months Ended

Sep. 29, 2018

Sep. 30, 2017

Oct. 01, 2016

Accumulated Other Comprehensive Income (Loss) [Roll Forward]

Other comprehensive income (loss)

$ (72)

$ 66

$ (56)

Net amount reclassified from accumulated other comprehensive income (loss)

(3)

^[1]

Provision for income taxes

(13)

(20)

Accumulated Other Comprehensive Loss [Member]

Accumulated Other Comprehensive Income (Loss) [Roll Forward]

Balance

(68)

(148)

(119)

Balance

(156)

(68)

(148)

Currency Translation [Member]

Accumulated Other Comprehensive Income (Loss) [Roll Forward]

Balance

(48)

(82)

(81)

Other comprehensive income (loss)

(127)

(1)

Net amount reclassified from accumulated other comprehensive income (loss)

^[1]

Provision for income taxes

Balance

(175)

(48)

(82)

Defined Benefit Pension and Retiree Health Benefit Plans [Member]

Accumulated Other Comprehensive Income (Loss) [Roll Forward]

Balance

(16)

(44)

(25)

Other comprehensive income (loss)

(25)

Net amount reclassified from accumulated other comprehensive income (loss)

(6)

^[1]

Provision for income taxes

(10)

Balance

(13)

(16)

(44)

Interest Rate Swaps [Member]

Accumulated Other Comprehensive Income (Loss) [Roll Forward]

Balance

(4)

(22)

(13)

Other comprehensive income (loss)

(30)

Net amount reclassified from accumulated other comprehensive income (loss)

^[1]

Provision for income taxes

(13)

(10)

Balance

$ 32

$ (4)

$ (22)

[1]	See footnote 4 for further discussion on amounts reclassified out of accumulated other comprehensive income (loss) related to interest rate swaps and footnote 9 for amounts reclassified related to pensions.

Acquisitions, Laddawn, Inc. (Details) - USD ($) $ in Millions	Aug. 31, 2018	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Acquisitions [Abstract]
Goodwill		$ 2,944	$ 2,775	$ 2,406
Laddawn [Member]
Acquisitions [Abstract]
Purchase price	$ 242
Working capital	26
Property and equipment	39
Intangible assets	95
Goodwill	$ 82

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($)
$ in Millions

Feb. 28, 2018

Sep. 29, 2018

Jan. 31, 2018

Sep. 30, 2017

Oct. 01, 2016

Allocation of Purchase Price [Abstract]

Goodwill

$ 2,944

$ 2,775

$ 2,406

4.50% Second Priority Senior Secured Notes due 2026 [Member]

Acquisitions [Abstract]

Face amount of debt issued

$ 500

Interest rate

4.50%

Clopay [Member]

Acquisitions [Abstract]

Purchase price

$ 475

Allocation of Purchase Price [Abstract]

Working capital

^[1]

Property and equipment

164

Intangible assets

125

Goodwill

110

Other assets and long-term liabilities

Step up of inventory to fair value

$ 3

[1]	Includes a $3 million step up of inventory to fair value

Acquisitions, Adchem Corp (Details) - USD ($) $ in Millions	1 Months Ended
Acquisitions, Adchem Corp (Details) - USD ($) $ in Millions	Jun. 30, 2017	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Acquisitions [Abstract]
Goodwill		$ 2,944	$ 2,775	$ 2,406
Adchem [Member]
Acquisitions [Abstract]
Purchase price	$ 49
Working capital	10
Property and equipment	2
Intangible assets	22
Goodwill	$ 15

Acquisitions, AEP Industries Inc. (Details) - AEP [Member] - USD ($) shares in Millions, $ in Millions	1 Months Ended	12 Months Ended
	Jan. 31, 2017	Sep. 30, 2017	Oct. 01, 2016
Acquisitions [Abstract]
Purchase price, net of cash acquired	$ 791
Number of shares issued (in shares)	6.4
Value of shares issued at time of closing	$ 324
Pro Forma Information [Abstract]
Pro forma net sales		$ 7,400	$ 7,600
Pro forma net income		$ 338	$ 250
Term Loan due January 2024 [Member]
Acquisitions [Abstract]
Face amount of debt issued	$ 500

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Jan. 31, 2018	Sep. 30, 2017
Long-term Debt [Abstract]
Long-term debt	$ 5,887
Debt discounts and deferred fees	(43)		$ (48)
Capital leases and other	135		132
Total long-term debt	5,844		5,641
Current portion of long-term debt	(38)		(33)
Long-term debt, less current portion	5,806		5,608
Term Loan due February 2020 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 800		1,000
Maturity date	Feb. 29, 2020
Term Loan due January 2021 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 814		814
Maturity date	Jan. 31, 2021
Term Loan due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 1,545		1,645
Maturity date	Oct. 31, 2022
Term Loan due January 2024 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 493		498
Maturity date	Jan. 31, 2024
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt	$ 0		0
Maturity date	May 31, 2020
5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500		500
Interest rate	5.50%
Maturity date	May 31, 2022
6% Second Priority Senior Secured Notes due October 2022 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 400		400
Interest rate	6.00%
Maturity date	Oct. 31, 2022
5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 700		700
Interest rate	5.125%
Maturity date	Jul. 31, 2023
4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]
Long-term Debt [Abstract]
Long-term debt	$ 500		$ 0
Interest rate	4.50%	4.50%
Maturity date	Feb. 28, 2026

Long-Term Debt, Fiscal 2018 Activity (Details) - 4 1/2% Second Priority Senior Secured Notes due February 2026 [Member] - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Jan. 31, 2018
Long-Term Debt [Abstract]
Face amount of debt issued		$ 500
Interest rate	4.50%	4.50%
Maturity date	Feb. 28, 2026
Debt discount		$ 4

Long-Term Debt, Berry Global, Inc. Senior Secured Credit Facility (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Long-Term Debt [Abstract]
Loss on extinguishment of debt	$ (2)	$ (10)	$ (4)
Repayment of long-term borrowings	335	$ 636	$ 524
Term Loans [Member]
Long-Term Debt [Abstract]
Face amount of debt issued	$ 3,700
Term Loan due February 2020 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due January 2021 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	1.75%
Term Loan due October 2022 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%
Term Loan due January 2024 [Member] \| LIBOR [Member]
Long-Term Debt [Abstract]
Basis spread on variable rate	2.00%
Revolving Line of Credit [Member]
Long-Term Debt [Abstract]
Maximum borrowing capacity	$ 750

Long-Term Debt, Future Maturities of Long-Term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Future Maturities of Long-Term Debt [Abstract]
2019	$ 38
2020	837
2021	842
2022	27
2023	2,458
Thereafter	1,685
Total	5,887
Interest paid	$ 253	$ 288	$ 276

Financial Instruments and Fair Value Measurements, Cross-Currency and Interest Rate Swaps (Details) € in Millions, $ in Millions	1 Months Ended		12 Months Ended
	Jun. 30, 2018 USD ($) Instrument	Jun. 30, 2013 USD ($)	Sep. 29, 2018 USD ($)	Nov. 30, 2017 EUR (€)	Feb. 28, 2013 USD ($)
Cross-Currency and Interest Rate Swaps [Abstract]
Number of derivative instruments settled \| Instrument	2
Cross-Currency Swaps [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap \| €				€ 250
Interest Rate Swap - February 2013 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap					$ 1,000
Cash received for settlement of derivative contract		$ 16
Interest Rate Swap - March 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Cash received for settlement of derivative contract	$ 9
Interest Rate Swap - February 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Cash received for settlement of derivative contract	$ 21
Interest Rate Swap - May 2017 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap			$ 450
Fixed annual rate of swap			2.00%
Interest Rate Swap - May 2017 [Member] \| LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate			1 month
Interest Rate Swap - June 2018 [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Notional amount of swap			$ 1,000
Fixed annual rate of swap			2.808%
Interest Rate Swap - June 2018 [Member] \| LIBOR [Member]
Cross-Currency and Interest Rate Swaps [Abstract]
Term of variable rate			1 month

Financial Instruments and Fair Value Measurements, Fair Value of Derivatives and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Cross-Currency Swaps [Member] \| Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 11	$ 0
Interest Rate Swaps [Member] \| Designated [Member] \| Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	16	1
Interest Rate Swaps [Member] \| Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	0	15
Interest Rate Swaps [Member] \| Not Designated [Member] \| Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	0	13
Interest Rate Swaps [Member] \| Not Designated [Member] \| Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 1	$ 13

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Income (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Derivative Instruments [Abstract]
Amortization related to unrealized losses in Accumulated other comprehensive loss for next 12 months	$ 11
Fair value of long-term indebtedness in excess of book value	5	$ 81
Cross-Currency Swaps [Member] \| Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	(5)	0	$ 0
Foreign Currency Swaps [Member] \| Other (Income) Expense [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	0	(2)	13
Interest Rate Swaps [Member] \| Interest Expense, Net [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (1)	$ 24	$ 16

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016	Oct. 01, 2011
Impairment [Abstract]
Indefinite-lived trademarks	$ 0	$ 0	$ 0
Goodwill	0	0	0	$ 165
Definite lived intangible assets	0	0	0
Property, plant, and equipment	0	2	3
Impairment charges	0	2	3
Fair Value on Nonrecurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248	248
Goodwill	2,944	2,775	2,406
Definite lived intangible assets	1,092	1,038	952
Property, plant, and equipment	2,488	2,366	2,224
Total	6,772	6,427	5,830
Fair Value on Nonrecurring Basis [Member] \| Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0	0
Goodwill	0	0	0
Definite lived intangible assets	0	0	0
Property, plant, and equipment	0	0	0
Total	0	0	0
Fair Value on Nonrecurring Basis [Member] \| Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0	0
Goodwill	0	0	0
Definite lived intangible assets	0	0	0
Property, plant, and equipment	0	0	0
Total	0	0	0
Fair Value on Nonrecurring Basis [Member] \| Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	248	248
Goodwill	2,944	2,775	2,406
Definite lived intangible assets	1,092	1,038	952
Property, plant, and equipment	2,488	2,366	2,224
Total	$ 6,772	$ 6,427	$ 5,830

Goodwill and Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Goodwill and Intangible Assets [Abstract]
Goodwill	$ 2,944	$ 2,775	$ 2,406
Accumulated amortization	(1,020)	(1,155)	(998)
Intangible assets, net	1,340	1,286	$ 1,200
Total goodwill and intangible assets, net	4,284	4,061
Future Amortization Expense for Definite Lived Intangibles [Abstract]
2019	157
2020	145
2021	133
2022	121
2023	110
Customer Relationships [Member]
Goodwill and Intangible Assets [Abstract]
Definite lived intangible assets	$ 1,882	1,922
Customer Relationships [Member] \| Minimum [Member]
Goodwill and Intangible Assets [Abstract]
Amortization period	5 years
Customer Relationships [Member] \| Maximum [Member]
Goodwill and Intangible Assets [Abstract]
Amortization period	15 years
Trademarks [Member]
Goodwill and Intangible Assets [Abstract]
Indefinite lived intangible assets	$ 248	248
Definite lived intangible assets	$ 45	87
Trademarks [Member] \| Maximum [Member]
Goodwill and Intangible Assets [Abstract]
Amortization period	15 years
Other Intangibles [Member]
Goodwill and Intangible Assets [Abstract]
Definite lived intangible assets	$ 185	$ 184
Other Intangibles [Member] \| Minimum [Member]
Goodwill and Intangible Assets [Abstract]
Amortization period	5 years
Other Intangibles [Member] \| Maximum [Member]
Goodwill and Intangible Assets [Abstract]
Amortization period	14 years

Lease and Other Commitments and Contingencies (Details) $ in Millions	12 Months Ended
	Sep. 29, 2018 USD ($) Employee	Sep. 30, 2017 USD ($)	Oct. 01, 2016 USD ($)
Lease and Other Commitments and Contingencies [Abstract]
New capital lease obligations	$ 31	$ 5	$ 51
Minimum lease payments or contingent rentals	29	27
Asset retirement obligations	10	9
Rent expense from operating leases	72	$ 67	$ 60
Future Minimum Lease Payments for Capital Leases [Abstract]
2019	37
2020	32
2021	27
2022	24
2023	10
Thereafter	19
Total net minimum payments	149
Less: amount representing interest	(14)
Present value of net minimum lease payments	135
Future Minimum Lease Payments for Operating Leases [Abstract]
2019	67
2020	56
2021	51
2022	44
2023	37
Thereafter	165
Total net minimum payments	420
Sale-Leaseback Transactions [Abstract]
Deferred gain on sale-leaseback transactions	$ 21
Collective Bargaining Agreements [Abstract]
Number of employees \| Employee	24,000
Percentage of employees covered by collective bargaining agreements	18.00%
Period of time with no significant work stoppages or other labor disputes with employees under collective bargaining agreements	3 years

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation, payroll, and other	$ 113	$ 147
Accrued taxes	72	90
Rebates	58	58
Interest	49	36
Tax receivable agreement obligation	16	35
Restructuring	13	19
Other	95	78
Accrued expenses and other current liabilities	$ 416	$ 463

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Lease retirement obligation	$ 39	$ 37
Uncertain tax positions	74	59	$ 62
Pension liability	45	56
Deferred purchase price	40	46
Tax receivable agreement obligation	23	34
Sale-lease back deferred gain	21	24
Transition tax	18	0
Derivative instruments	12	27
Other	17	17
Other long-term liabilities	$ 289	$ 300

Income Taxes, Components of Income Tax Expense (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 29, 2018	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Income Taxes [Abstract]
U. S. corporate income tax rate	21.00%
Transition tax benefit		$ (124)
Repatriation tax charge		21
Net deferred tax revaluation benefit		(145)
Current [Abstract]
U.S. Federal		19	$ 40	$ 0
U.S. State		8	6	5
Non-U.S.		40	58	36
Total current		67	104	41
Deferred [Abstract]
U.S. Federal		(72)	34	35
U.S. State		12	(10)	3
Non-U.S.		(26)	(19)	(7)
Total deferred		(86)	5	31
Expense for income taxes		(19)	109	72
U.S. income from continuing operations before income taxes		373	313	168
Non-U.S. income from continuing operations before income taxes		$ 104	$ 136	$ 140

Income Taxes, Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Income Taxes [Abstract]
U.S. Federal income tax expense at the statutory rate	$ 117	$ 157	$ 108
Adjustments to Reconcile to the Income Tax Provision [Abstract]
U.S. state income tax expense	12	6	8
Changes in state valuation allowance	0	(9)	2
Research and development credits	(7)	(7)	(8)
Share-based compensation	(8)	(33)	(15)
U.S. tax reform	(124)	0	0
Permanent differences	0	2	2
Changes in foreign valuation allowance	(10)	3	(1)
Foreign income taxed in the U.S.	0	0	7
Manufacturing tax benefits	(6)	(6)	0
Deduction of worthless investment	0	0	(9)
Permanent foreign currency differences	0	(1)	(8)
Rate differences between U.S. and foreign	3	(11)	(14)
Other	4	8	0
Expense for income taxes	$ (19)	$ 109	$ 72

Income Taxes, Net Deferred Income Tax Liability (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Deferred Tax Assets [Abstract]
Allowance for doubtful accounts	$ 4	$ 7
Deferred gain on sale-leaseback	6	10
Accrued liabilities and reserves	28	89
Inventories	9	6
Net operating loss carryforward	212	292
Alternative minimum tax (AMT) credit carryforward	8	11
Research and development credit carryforward	13	18
Federal and state tax credits	10	9
Other	19	14
Total deferred tax assets	309	456
Valuation allowance	(93)	(93)
Total deferred tax assets, net of valuation allowance	216	363
Deferred Tax Liabilities [Abstract]
Property, plant and equipment	239	277
Intangible assets	306	475
Debt extinguishment	0	27
Other	5	3
Total deferred tax liabilities	550	782
Net deferred tax liability	(334)	(419)
Net deferred tax assets	31
Net deferred tax liabilities	$ 365	$ 419

Income Taxes, Net Operating Loss and Tax Credit Carryforwards (Details) $ in Millions	Sep. 29, 2018 USD ($)
AMT Credit Carryforwards [Member]
Income Taxes [Abstract]
Tax credit carryforwards	$ 8
Federal [Member]
Income Taxes [Abstract]
Operating loss carryforwards	357
State [Member]
Income Taxes [Abstract]
Operating loss carryforwards	1,114
State [Member] \| Research and Development Tax Credits [Member]
Income Taxes [Abstract]
Tax credit carryforwards	13
State [Member] \| Other Tax Credits [Member]
Income Taxes [Abstract]
Tax credit carryforwards	10
Foreign [Member]
Income Taxes [Abstract]
Operating loss carryforwards	$ 322

Income Taxes, Income Tax Receivable Agreement (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2018	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Income Taxes [Abstract]
Percentage of cash savings paid under tax receivable agreement		85.00%
Adjustment to Paid-in capital for obligation under tax receivable agreement		$ 313
Payment of tax receivable agreement		37	$ 111	$ 57
Balance payable under tax receivable agreement		39
Deferred tax assets valuation allowance		93	93
Income taxes paid		60	$ 41	$ 43
Repatriation tax charge		$ 21
Maximum [Member]
Income Taxes [Abstract]
Period Federal net operating loss carryforwards should be available for use		16 years
Subsequent Event [Member]
Income Taxes [Abstract]
Payment of tax receivable agreement	$ 16

Income Taxes, Uncertain Tax Positions (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Gross Unrecognized Tax Benefits [Roll Forward]
Beginning unrecognized tax benefits	$ 59	$ 62
Gross increases - tax positions in prior periods	1	1
Gross increases - current period tax positions	19	4
Gross decreases - tax positions in prior periods	0	(1)
Settlements	0	(3)
Lapse of statue of limitations	(5)	(4)
Ending unrecognized tax benefits	74	$ 59
Unrecognized tax benefits that would affect effective tax rate if recognized	72
Interest and penalties accrued for uncertain tax positions	$ 23

Retirement Plans, Change in Projected Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($)
$ in Millions

12 Months Ended

Sep. 29, 2018

Sep. 30, 2017

Oct. 01, 2016

Defined Contribution 401 (k) Retirement Plan [Abstract]

Defined contribution plan expense

$ 20

$ 18

$ 10

Change in Projected Benefit Obligations (PBO) [Roll Forward]

Interest cost

Change in Fair Value of Plan Assets [Roll Forward]

Plan assets at beginning of period

291

Plan assets at end of period

277

291

(10)

Net unrealized losses in accumulated other comprehensive loss

(31)

Amount expected to be amortized from accumulated other comprehensive loss in fiscal 2018

$ 2

Period of time to recognize remaining net unrealized losses

11 years

Defined Benefit Pension Plans [Member]

Change in Projected Benefit Obligations (PBO) [Roll Forward]

PBO at beginning of period

$ 330

492

Interest cost

Actuarial loss (gain)

(17)

(15)

Plan conversion

(139)

^[1]

Benefit settlements

(3)

Benefits paid

(17)

(16)

PBO at end of period

307

330

492

Change in Fair Value of Plan Assets [Roll Forward]

Plan assets at beginning of period

291

418

Actual return on plan assets

Company contributions

Plan conversion

(136)

^[1]

Benefit settlements

(2)

Benefits paid

(17)

(18)

Plan assets at end of period

277

291

418

Net amount recognized

(30)

(39)

Retiree Health Plan [Member]

Change in Projected Benefit Obligations (PBO) [Roll Forward]

PBO at beginning of period

Interest cost

Actuarial loss (gain)

(1)

Change in Fair Value of Plan Assets [Roll Forward]

Plan assets at beginning of period

Actual return on plan assets

Company contributions

Plan conversion

Benefit settlements

Benefits paid

(1)

Plan assets at end of period

$ 0

Net amount recognized

$ (6)

$ (7)

[1]

Retirement Plans, Weighted Average Assumptions Used to Determine Benefit Obligation and Benefit Cost (Details)	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Health-Care-Cost Trend Rates [Abstract]
Assumed health-care-cost trend rate	7.00%
Defined Benefit Pension Plans [Member]
Weighted-Average Assumptions [Abstract]
Discount rate for benefit obligation	4.00%	3.50%
Discount rate for net benefit cost	3.50%	3.20%
Expected return on plan assets for net benefit costs	6.10%	6.40%
Retiree Health Plan [Member]
Weighted-Average Assumptions [Abstract]
Discount rate for benefit obligation	3.80%	3.30%
Discount rate for net benefit cost	3.30%	2.90%
Expected return on plan assets for net benefit costs	0.00%	0.00%

Retirement Plans, Fair Value of Plan Assets (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Retirement Plans [Abstract]
Fair value of plan assets	$ 277	$ 291
Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	94	107
Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	175	175
Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	8	9
Cash and Cash Equivalents [Member]
Retirement Plans [Abstract]
Fair value of plan assets	6	6
Cash and Cash Equivalents [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	6	6
Cash and Cash Equivalents [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Cash and Cash Equivalents [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Large Cap Comingled Equity Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	67	61
U.S. Large Cap Comingled Equity Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Large Cap Comingled Equity Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	67	61
U.S. Large Cap Comingled Equity Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Mid Cap Equity Mutual Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	50	57
U.S. Mid Cap Equity Mutual Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	50	57
U.S. Mid Cap Equity Mutual Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Mid Cap Equity Mutual Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Small Cap Equity Mutual Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	3	3
U.S. Small Cap Equity Mutual Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	3	3
U.S. Small Cap Equity Mutual Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
U.S. Small Cap Equity Mutual Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
International Equity Mutual Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	15	14
International Equity Mutual Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	15	14
International Equity Mutual Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
International Equity Mutual Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Real Estate Equity Investment Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	3	4
Real Estate Equity Investment Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	3	4
Real Estate Equity Investment Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Real Estate Equity Investment Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Corporate Bond Mutual Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	11	17
Corporate Bond Mutual Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	11	17
Corporate Bond Mutual Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Corporate Bond Mutual Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Corporate Bonds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	108	114
Corporate Bonds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Corporate Bonds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	108	114
Corporate Bonds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Guaranteed Investment Account [Member]
Retirement Plans [Abstract]
Fair value of plan assets	8	9
Guaranteed Investment Account [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Guaranteed Investment Account [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
Guaranteed Investment Account [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	8	9
International Fixed Income Funds [Member]
Retirement Plans [Abstract]
Fair value of plan assets	6	6
International Fixed Income Funds [Member] \| Level 1 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	6	6
International Fixed Income Funds [Member] \| Level 2 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	0	0
International Fixed Income Funds [Member] \| Level 3 [Member]
Retirement Plans [Abstract]
Fair value of plan assets	$ 0	$ 0

Retirement Plans, Expected Future Benefit Payments (Details) $ in Millions	Sep. 29, 2018 USD ($)
Defined Benefit Pension Plans [Member]
Expected Future Benefit Payments [Abstract]
2019	$ 18
2020	18
2021	19
2022	19
2023	19
2024-2028	96
Retiree Health Plan [Member]
Expected Future Benefit Payments [Abstract]
2019	1
2020	1
2021	1
2022	0
2023	0
2024-2028	$ 2

Retirement Plans, Net Pension and Retiree Health Benefit Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Retirement Plans [Abstract]
Service cost	$ 0	$ 0	$ 3
Interest cost	11	11	16
Amortization of net actuarial loss	2	3	2
Expected return on plan assets	(17)	(17)	(20)
Net periodic benefit cost	$ (4)	$ (3)	$ 1

Retirement Plans, Plan Asset Allocations (Details) - Defined Benefit Pension Plans [Member] - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Retirement Plans [Abstract]
Actual plan asset allocation	100.00%	100.00%
Equity Securities and Equity-Like Instruments [Member]
Retirement Plans [Abstract]
Actual plan asset allocation	50.00%	48.00%
Company Common Stock [Member]
Retirement Plans [Abstract]
Company stock held in plan assets	$ 43
Debt Securities and Debt-Like [Member]
Retirement Plans [Abstract]
Actual plan asset allocation	45.00%	47.00%
Other [Member]
Retirement Plans [Abstract]
Actual plan asset allocation	5.00%	5.00%

Restructuring and Impairment Charges, Restructuring Charges (Details) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 30, 2017 USD ($)	Sep. 30, 2017 USD ($)	Jul. 01, 2017 USD ($)	Apr. 01, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 29, 2018 USD ($) Segment Facility	Sep. 30, 2017 USD ($) Facility	Oct. 01, 2016 USD ($) Facility
Restructuring Charges [Abstract]
Number of operating segments \| Segment									3
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Expected Restructuring Costs [Abstract]
Expected total costs	95								95
Cumulative charges through Fiscal 2017	92								92
To be recognized in future	3								3
Severance and Termination Benefits [Member]
Expected Restructuring Costs [Abstract]
Expected total costs	75								75
Cumulative charges through Fiscal 2017	75								75
To be recognized in future	0								0
Facility Exit Costs [Member]
Expected Restructuring Costs [Abstract]
Expected total costs	15								15
Cumulative charges through Fiscal 2017	12								12
To be recognized in future	3								3
Asset Impairment [Member]
Expected Restructuring Costs [Abstract]
Expected total costs	5								5
Cumulative charges through Fiscal 2017	5								5
To be recognized in future	$ 0								$ 0
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Number of facilities shut down \| Facility									1		1
Number of facilities announced to be shut down \| Facility											1
Number of facilities to be shut down \| Facility											2
Net sales									$ 15	$ 12	$ 36
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Number of facilities shut down \| Facility									1	1
Net sales									$ 30	$ 5
Engineered Materials [Member]
Restructuring Charges [Abstract]
Number of facilities shut down \| Facility									1
Net sales									$ 10

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Restructuring Charges [Abstract]
Restructuring charges	$ 36	$ 24	$ 32
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	6	5	3
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	27	11	20
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 3	$ 8	$ 9

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Restructuring Accrual [Roll Forward]
Beginning balance	$ 19	$ 13
Acquisition		13
Charges	36	24	$ 32
Non-cash asset impairment	0	(2)	(3)
Cash payments	(42)	(29)
Ending balance	13	19	13
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	14	7
Acquisition		13
Charges	34	18
Non-cash asset impairment		0
Cash payments	(39)	(24)
Ending balance	9	14	7
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	5	6
Acquisition		0
Charges	2	4
Non-cash asset impairment		0
Cash payments	(3)	(5)
Ending balance	4	5	6
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	0	0
Acquisition		0
Charges	0	2
Non-cash asset impairment		(2)
Cash payments	0	0
Ending balance	$ 0	$ 0	$ 0

Stockholders' Equity, Share Repurchases (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Sep. 29, 2018	Aug. 31, 2018
Stockholders' Equity [Abstract]
Authorized amount of share repurchase program		$ 500
Number of shares repurchased and retired (in shares)	731
Shares repurchased and retired	$ 35
Average price of shares repurchased (in dollars per share)	$ 47.75
Common stock, par value (in dollars per share)	$ 0.01

Stockholders' Equity, Equity Incentive Plans (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Stockholders' Equity [Abstract]
Stock-based compensation expense	$ 23	$ 20	$ 20
Intrinsic value of options exercised	$ 35
2015 Plan [Member]
Stockholders' Equity [Abstract]
Shares authorized for grant (in shares)	12.5
Increase in shares authorized for grant (in shares)		5.0

Stockholders' Equity, Stock Option Activity (Details) - $ / shares shares in Thousands	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Number of Shares [Roll Forward]
Options outstanding, beginning of period (in shares)	10,760	11,716
Options granted (in shares)	1,453	1,820
Options exercised (in shares)	(1,176)	(2,562)
Options forfeited or cancelled (in shares)	(293)	(214)
Options outstanding, end of period (in shares)	10,744	10,760
Weighted Average Exercise Price [Roll Forward]
Options outstanding, beginning of period (in dollars per share)	$ 28.18	$ 21.44
Options granted (in dollars per share)	54.33	49.53
Options exercised (in dollars per share)	18.62	12.07
Options forfeited or cancelled (in dollars per share)	41.30	33.52
Options outstanding, end of period (in dollars per share)	32.40	28.18
Additional Information [Abstract]
Option price range at end of period, lower limit (in dollars per share)	3.04	3.04
Option price range at end of period, upper limit (in dollars per share)	$ 54.33	$ 49.53
Options exercisable at end of period (in shares)	5,154	4,108
Options available for grant at period end (in shares)	6,422	2,875
Weighted average fair value of options granted during period (in dollars per share)	$ 17.84	$ 15.52

Stockholders' Equity, Valuation Assumptions used for Options Granted (Details)	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Weighted Average Assumptions [Abstract]
Risk-free interest rate	2.70%	2.20%	1.20%
Dividend yield	0.00%	0.00%	0.00%
Volatility factor	26.10%	26.00%	25.70%
Expected option life	6 years 6 months	6 years 6 months	6 years 6 months

Stockholders' Equity, Options Outstanding (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017
Stockholders' Equity [Abstract]
Range of exercise prices, lower limit (in dollars per share)	$ 3.04	$ 3.04
Range of exercise prices, upper limit (in dollars per share)	$ 54.33	$ 49.53
Number exercisable options (in shares)	5,154	4,108
$ 3.04-54.33 [Member]
Stockholders' Equity [Abstract]
Range of exercise prices, lower limit (in dollars per share)	$ 3.04
Range of exercise prices, upper limit (in dollars per share)	$ 54.33
Number outstanding options (in shares)	10,744
Intrinsic value of outstanding options	$ 172
Weighted remaining contractual life	6 years 6 months
Weighted exercise price (in dollars per share)	$ 32.40
Number exercisable options (in shares)	5,154
Intrinsic value of exercisable options	$ 120
Unrecognized compensation	$ 25
Weighted recognition period	1 year 10 months 24 days

Segment and Geographic Data, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 30, 2017 USD ($)	Sep. 30, 2017 USD ($)	Jul. 01, 2017 USD ($)	Apr. 01, 2017 USD ($)	Dec. 31, 2016 USD ($)	Sep. 29, 2018 USD ($) Segment	Sep. 30, 2017 USD ($)	Oct. 01, 2016 USD ($)
Segment and Geographic Data [Abstract]
Number of reportable segments \| Segment									3
Selected Information by Reportable Segment [Abstract]
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Operating income									761	732	581
Depreciation and amortization									538	521	525
Total assets	9,131				8,476				9,131	8,476
Goodwill	2,944				2,775				2,944	2,775	2,406
Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									10
Goodwill	633				545				633	545	85
Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									30	5
Goodwill	902				819				902	819	801
Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									15	12	36
Goodwill	1,409				1,411				$ 1,409	$ 1,411	$ 1,520
Net Sales [Member] \| Engineered Materials [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									100.00%	100.00%	100.00%
Net Sales [Member] \| Health, Hygiene & Specialties [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									100.00%	100.00%	100.00%
Net Sales [Member] \| Consumer Packaging [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									100.00%	100.00%	100.00%
North America [Member] \| Net Sales [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									82.00%
North America [Member] \| Long-Lived Assets [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									84.00%
North America [Member] \| Total Assets [Member]
Segment and Geographic Data [Abstract]
Concentration risk percentage									84.00%
Operating Segment [Member] \| Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									$ 2,672	$ 2,375	$ 1,627
Operating income									368	316	182
Depreciation and amortization									109	106	82
Total assets	1,998				1,803				1,998	1,803
Goodwill	633				545				633	545
Operating Segment [Member] \| Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									2,734	2,369	2,400
Operating income									202	216	196
Depreciation and amortization									200	184	199
Total assets	3,913				3,496				3,913	3,496
Goodwill	902				819				902	819
Operating Segment [Member] \| Consumer Packaging [Member]
Selected Information by Reportable Segment [Abstract]
Net sales									2,463	2,351	2,462
Operating income									191	200	203
Depreciation and amortization									229	231	$ 244
Total assets	3,220				3,177				3,220	3,177
Goodwill	$ 1,409				$ 1,411				$ 1,409	$ 1,411

Segment and Geographic Data, Selected Information by Geography (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Selected Information by Geography [Abstract]
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Long-lived assets	6,846				6,472				6,846	6,472
Reportable Geography [Member] \| North America [Member]
Selected Information by Geography [Abstract]
Net sales									6,474	5,850	5,250
Long-lived assets	5,764				5,303				5,764	5,303
Reportable Geography [Member] \| South America [Member]
Selected Information by Geography [Abstract]
Net sales									332	333	336
Long-lived assets	320				418				320	418
Reportable Geography [Member] \| Europe [Member]
Selected Information by Geography [Abstract]
Net sales									807	646	661
Long-lived assets	463				467				463	467
Reportable Geography [Member] \| Asia [Member]
Selected Information by Geography [Abstract]
Net sales									256	266	$ 242
Long-lived assets	$ 299				$ 284				$ 299	$ 284

Segment and Geographic Data, Selected Information by Product Line (Details) - Net Sales [Member]	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Engineered Materials [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%
Engineered Materials [Member] \| Core Films [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	46.00%	49.00%	72.00%
Engineered Materials [Member] \| Retail & Industrial [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	54.00%	51.00%	28.00%
Health, Hygiene & Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%
Health, Hygiene & Specialties [Member] \| Health [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	19.00%	22.00%	20.00%
Health, Hygiene & Specialties [Member] \| Hygiene [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	43.00%	44.00%	45.00%
Health, Hygiene & Specialties [Member] \| Specialties [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	38.00%	34.00%	35.00%
Consumer Packaging [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	100.00%	100.00%	100.00%
Consumer Packaging [Member] \| Rigid Open Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	44.00%	43.00%	42.00%
Consumer Packaging [Member] \| Rigid Closed Top [Member]
Selected Information by Product Line [Abstract]
Concentration risk percentage	56.00%	57.00%	58.00%

Net Income per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Net Income per Share [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)									0.0
Numerator [Abstract]
Net income attributable to the Company	$ 133	$ 110	$ 90	$ 163	$ 110	$ 107	$ 72	$ 51	$ 496	$ 340	$ 236
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)									131.4	127.6	120.8
Dilutive shares (in shares)									3.8	5.0	4.2
Weighted average common and common equivalent shares outstanding - diluted (in shares)									135.2	132.6	125.0
Per Common Share Income [Abstract]
Basic (in dollars per share)	$ 1.01	$ 0.84	$ 0.69	$ 1.24	$ 0.84	$ 0.82	$ 0.56	$ 0.42	$ 3.77	$ 2.66	$ 1.95
Diluted (in dollars per share)	$ 0.99	$ 0.81	$ 0.66	$ 1.20	$ 0.81	$ 0.79	$ 0.54	$ 0.40	$ 3.67	$ 2.56	$ 1.89

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Operations (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Guarantor and Non-Guarantor Financial Information [Abstract]
Percentage ownership in guarantor subsidiaries									100.00%
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Cost of goods sold	1,705	1,690	1,596	1,447	1,514	1,518	1,453	1,206	6,438	5,691	5,202
Selling, general and administrative									480	494	531
Amortization of intangibles									154	154	143
Restructuring and impairment charges									36	24	32
Operating income									761	732	581
Other (income) expense, net									25	14	(18)
Interest expense, net									259	269	291
Equity in net income of subsidiaries									0	0	0
Income (loss) before income taxes									477	449	308
Income tax expense (benefit)									(19)	109	72
Net income (loss)	$ 133	$ 110	$ 90	$ 163	$ 110	$ 107	$ 72	$ 51	496	340	236
Currency translation									(127)	34	(1)
Interest rate hedges									49	28	(14)
Defined benefit pension and retiree health benefit plans									3	38	(23)
Provision for income taxes related to other comprehensive income items									(13)	(20)	9
Comprehensive income (loss)									408	420	207
Eliminations [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales									0	0	0
Cost of goods sold									0	0	0
Selling, general and administrative									0	0	0
Amortization of intangibles									0	0	0
Restructuring and impairment charges									0	0	0
Operating income									0	0	0
Other (income) expense, net									0	0	0
Interest expense, net									0	0	0
Equity in net income of subsidiaries									784	790	587
Income (loss) before income taxes									(784)	(790)	(587)
Income tax expense (benefit)									19	(109)	(71)
Net income (loss)									(803)	(681)	(516)
Currency translation									127	(34)	1
Interest rate hedges									(49)	(38)	14
Defined benefit pension and retiree health benefit plans									(3)	(28)	23
Provision for income taxes related to other comprehensive income items									13	20	(9)
Comprehensive income (loss)									(715)	(761)	(487)
Parent [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales									0	0	0
Cost of goods sold									0	0	0
Selling, general and administrative									0	0	0
Amortization of intangibles									0	0	0
Restructuring and impairment charges									0	0	0
Operating income									0	0	0
Other (income) expense, net									0	0	0
Interest expense, net									0	0	0
Equity in net income of subsidiaries									(477)	(449)	(308)
Income (loss) before income taxes									477	449	308
Income tax expense (benefit)									(19)	109	72
Net income (loss)									496	340	236
Currency translation									(127)	34	(1)
Interest rate hedges									49	28	(14)
Defined benefit pension and retiree health benefit plans									3	38	(23)
Provision for income taxes related to other comprehensive income items									(13)	(20)	9
Comprehensive income (loss)									408	420	207
Issuer [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales									574	587	599
Cost of goods sold									346	438	476
Selling, general and administrative									63	55	72
Amortization of intangibles									1	6	8
Restructuring and impairment charges									0	0	0
Operating income									164	88	43
Other (income) expense, net									8	8	15
Interest expense, net									8	12	36
Equity in net income of subsidiaries									(307)	(341)	(279)
Income (loss) before income taxes									455	409	271
Income tax expense (benefit)									(41)	69	34
Net income (loss)									496	340	237
Currency translation									(11)	0	0
Interest rate hedges									49	28	(14)
Defined benefit pension and retiree health benefit plans									0	25	(10)
Provision for income taxes related to other comprehensive income items									(13)	(20)	9
Comprehensive income (loss)									521	373	222
Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales									5,465	4,861	4,220
Cost of goods sold									4,558	3,920	3,388
Selling, general and administrative									309	335	324
Amortization of intangibles									127	120	107
Restructuring and impairment charges									20	14	28
Operating income									451	472	373
Other (income) expense, net									8	(1)	(211)
Interest expense, net									225	229	205
Equity in net income of subsidiaries									0	0	0
Income (loss) before income taxes									218	244	379
Income tax expense (benefit)									(2)	0	8
Net income (loss)									220	244	371
Currency translation									(3)	0	0
Interest rate hedges									0	0	0
Defined benefit pension and retiree health benefit plans									0	0	0
Provision for income taxes related to other comprehensive income items									0	0	0
Comprehensive income (loss)									217	244	371
Non-Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Operations [Abstract]
Net sales									1,830	1,647	1,670
Cost of goods sold									1,534	1,333	1,338
Selling, general and administrative									108	104	135
Amortization of intangibles									26	28	28
Restructuring and impairment charges									16	10	4
Operating income									146	172	165
Other (income) expense, net									9	7	178
Interest expense, net									26	28	50
Equity in net income of subsidiaries									0	0	0
Income (loss) before income taxes									111	137	(63)
Income tax expense (benefit)									24	40	29
Net income (loss)									87	97	(92)
Currency translation									(113)	34	(1)
Interest rate hedges									0	0	0
Defined benefit pension and retiree health benefit plans									3	13	(13)
Provision for income taxes related to other comprehensive income items									0	0	0
Comprehensive income (loss)									$ (23)	$ 144	$ (106)

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Balance Sheet (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017	Dec. 31, 2016	Oct. 01, 2016	Jan. 02, 2016	Sep. 26, 2015
Current assets [Abstract]
Cash and cash equivalents	$ 381	$ 306	$ 306	$ 323	$ 323	$ 228
Accounts receivable, net	941	847
Intercompany receivable	0	0
Inventories	887	762
Prepaid expenses and other current	76	89
Total current assets	2,285	2,004
Property, plant and equipment, net	2,488	2,366
Goodwill and intangible assets, net	4,284	4,061
Investment in subsidiaries	0	0
Other assets	74	45
Total assets	9,131	8,476
Current liabilities [Abstract]
Accounts payable	783	638
Accrued expenses and other current liabilities	416	463
Intercompany payable	0	0
Current portion of long-term debt	38	33
Total current liabilities	1,237	1,134
Long-term debt, less current portion	5,806	5,608
Deferred income taxes	365	419
Other long-term liabilities	289	300
Total long-term liabilities	6,460	6,327
Total liabilities	7,697	7,461
Total equity (deficit)	1,434	1,015		221		(65)
Total liabilities and stockholders' equity	9,131	8,476
Eliminations [Member]
Current assets [Abstract]
Cash and cash equivalents	0	0	0	0	0	0
Accounts receivable, net	0	0
Intercompany receivable	(2,252)	(2,729)
Inventories	0	0
Prepaid expenses and other current	0	0
Total current assets	(2,252)	(2,729)
Property, plant and equipment, net	0	0
Goodwill and intangible assets, net	0	0
Investment in subsidiaries	(8,769)	(7,337)
Other assets	0	0
Total assets	(11,021)	(10,066)
Current liabilities [Abstract]
Accounts payable	0	0
Accrued expenses and other current liabilities	0	0
Intercompany payable	(2,252)	(2,729)
Current portion of long-term debt	0	0
Total current liabilities	(2,252)	(2,729)
Long-term debt, less current portion	0	0
Deferred income taxes	0	0
Other long-term liabilities	0	0
Total long-term liabilities	0	0
Total liabilities	(2,252)	(2,729)
Total equity (deficit)	(8,769)	(7,337)
Total liabilities and stockholders' equity	(11,021)	(10,066)
Parent [Member]
Current assets [Abstract]
Cash and cash equivalents	0	0	0	0	0	0
Accounts receivable, net	0	0
Intercompany receivable	296	512
Inventories	0	0
Prepaid expenses and other current	0	0
Total current assets	296	512
Property, plant and equipment, net	0	0
Goodwill and intangible assets, net	0	0
Investment in subsidiaries	1,513	992
Other assets	31	0
Total assets	1,840	1,504
Current liabilities [Abstract]
Accounts payable	0	0
Accrued expenses and other current liabilities	18	36
Intercompany payable	0	0
Current portion of long-term debt	0	0
Total current liabilities	18	36
Long-term debt, less current portion	0	0
Deferred income taxes	365	419
Other long-term liabilities	23	34
Total long-term liabilities	388	453
Total liabilities	406	489
Total equity (deficit)	1,434	1,015
Total liabilities and stockholders' equity	1,840	1,504
Issuer [Member]
Current assets [Abstract]
Cash and cash equivalents	133	18	18	102	102	163
Accounts receivable, net	42	49
Intercompany receivable	1,907	2,217
Inventories	56	42
Prepaid expenses and other current	18	7
Total current assets	2,156	2,333
Property, plant and equipment, net	79	80
Goodwill and intangible assets, net	79	79
Investment in subsidiaries	6,151	5,240
Other assets	17	16
Total assets	8,482	7,748
Current liabilities [Abstract]
Accounts payable	42	43
Accrued expenses and other current liabilities	146	168
Intercompany payable	0	0
Current portion of long-term debt	30	32
Total current liabilities	218	243
Long-term debt, less current portion	5,782	5,579
Deferred income taxes	0	0
Other long-term liabilities	163	128
Total long-term liabilities	5,945	5,707
Total liabilities	6,163	5,950
Total equity (deficit)	2,319	1,798
Total liabilities and stockholders' equity	8,482	7,748
Guarantor Subsidiaries [Member]
Current assets [Abstract]
Cash and cash equivalents	4	12	12	5	5	0
Accounts receivable, net	555	503
Intercompany receivable	0	0
Inventories	664	567
Prepaid expenses and other current	17	31
Total current assets	1,240	1,113
Property, plant and equipment, net	1,684	1,564
Goodwill and intangible assets, net	3,742	3,476
Investment in subsidiaries	1,105	1,105
Other assets	2	2
Total assets	7,773	7,260
Current liabilities [Abstract]
Accounts payable	468	356
Accrued expenses and other current liabilities	159	181
Intercompany payable	2,252	2,667
Current portion of long-term debt	8	0
Total current liabilities	2,887	3,204
Long-term debt, less current portion	23	29
Deferred income taxes	0	0
Other long-term liabilities	45	70
Total long-term liabilities	68	99
Total liabilities	2,955	3,303
Total equity (deficit)	4,818	3,957
Total liabilities and stockholders' equity	7,773	7,260
Non-Guarantor Subsidiaries [Member]
Current assets [Abstract]
Cash and cash equivalents	244	276	$ 276	$ 216	$ 216	$ 65
Accounts receivable, net	344	295
Intercompany receivable	49	0
Inventories	167	153
Prepaid expenses and other current	41	51
Total current assets	845	775
Property, plant and equipment, net	725	722
Goodwill and intangible assets, net	463	506
Investment in subsidiaries	0	0
Other assets	24	27
Total assets	2,057	2,030
Current liabilities [Abstract]
Accounts payable	273	239
Accrued expenses and other current liabilities	93	78
Intercompany payable	0	62
Current portion of long-term debt	0	1
Total current liabilities	366	380
Long-term debt, less current portion	1	0
Deferred income taxes	0	0
Other long-term liabilities	58	68
Total long-term liabilities	59	68
Total liabilities	425	448
Total equity (deficit)	1,632	1,582
Total liabilities and stockholders' equity	$ 2,057	$ 2,030

Guarantor and Non-Guarantor Financial Information, Condensed Supplemental Consolidated Statements of Cash Flows (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	$ 1,004	$ 975	$ 857
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(336)	(269)	(288)
Proceeds from sale of assets	3	6	5
(Contributions) distributions to/from subsidiaries	0	0	0
Intercompany advances (repayments)	0	0	0
Acquisition of business, net of cash acquired	(702)	(515)	(2,283)
Other investing activities, net	0	4	(13)
Net cash from investing activities	(1,035)	(774)	(2,579)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	498	495	2,490
Repayment of long-term borrowings	(335)	(636)	(524)
Proceeds from issuance of common stock	23	31	26
Repurchase of common stock	(33)	0	0
Payment of tax receivable agreement	(37)	(111)	(57)
Debt financing costs	(3)	(5)	(40)
Purchase of non-controlling interest	0	0	(78)
Changes in intercompany balances	0	0	0
Contribution from Parent	0	0	0
Net cash from financing activities	113	(226)	1,817
Effect of currency translation on cash	(7)	8	0
Net change in cash and cash equivalents	75	(17)	95
Cash and cash equivalents at beginning of period	306	323	228
Cash and cash equivalents at end of period	381	306	323
Eliminations [Member]
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	0	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0	0
Proceeds from sale of assets	0	0	0
(Contributions) distributions to/from subsidiaries	705	515	2,260
Intercompany advances (repayments)	(538)	(428)	(96)
Acquisition of business, net of cash acquired	0	0	0
Other investing activities, net		0	0
Net cash from investing activities	167	87	2,164
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	0	0	0
Repayment of long-term borrowings	0	0	0
Proceeds from issuance of common stock	0	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0	0
Debt financing costs	0	0	0
Purchase of non-controlling interest			0
Changes in intercompany balances	538	428	96
Contribution from Parent	(705)	(515)	(2,260)
Net cash from financing activities	(167)	(87)	(2,164)
Effect of currency translation on cash	0	0	0
Net change in cash and cash equivalents	0	0	0
Cash and cash equivalents at beginning of period	0	0	0
Cash and cash equivalents at end of period	0	0	0
Parent [Member]
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	0	0	0
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	0	0	0
Proceeds from sale of assets	0	0	0
(Contributions) distributions to/from subsidiaries	10	(31)	(26)
Intercompany advances (repayments)	0	0	0
Acquisition of business, net of cash acquired	0	0	0
Other investing activities, net		0	0
Net cash from investing activities	10	(31)	(26)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	0	0	0
Repayment of long-term borrowings	0	0	0
Proceeds from issuance of common stock	23	31	26
Repurchase of common stock	(33)
Payment of tax receivable agreement	(37)	(111)	(57)
Debt financing costs	0	0	0
Purchase of non-controlling interest			0
Changes in intercompany balances	37	111	57
Contribution from Parent	0	0	0
Net cash from financing activities	(10)	31	26
Effect of currency translation on cash	0	0	0
Net change in cash and cash equivalents	0	0	0
Cash and cash equivalents at beginning of period	0	0	0
Cash and cash equivalents at end of period	0	0	0
Issuer [Member]
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	133	128	103
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(5)	(19)	(13)
Proceeds from sale of assets	0	1	0
(Contributions) distributions to/from subsidiaries	(715)	(484)	(2,234)
Intercompany advances (repayments)	538	428	96
Acquisition of business, net of cash acquired	0	0	0
Other investing activities, net		4	(13)
Net cash from investing activities	(182)	(70)	(2,164)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	498	495	2,490
Repayment of long-term borrowings	(331)	(632)	(450)
Proceeds from issuance of common stock	0	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0	0
Debt financing costs	(3)	(5)	(40)
Purchase of non-controlling interest			0
Changes in intercompany balances	0	0	0
Contribution from Parent	0	0	0
Net cash from financing activities	164	(142)	2,000
Effect of currency translation on cash	0	0	0
Net change in cash and cash equivalents	115	(84)	(61)
Cash and cash equivalents at beginning of period	18	102	163
Cash and cash equivalents at end of period	133	18	102
Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	651	647	566
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(241)	(209)	(239)
Proceeds from sale of assets	3	5	5
(Contributions) distributions to/from subsidiaries	0	0	0
Intercompany advances (repayments)	0	0	0
Acquisition of business, net of cash acquired	(632)	(515)	(368)
Other investing activities, net		0	0
Net cash from investing activities	(870)	(719)	(602)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	0	0	0
Repayment of long-term borrowings	(3)	(3)	(23)
Proceeds from issuance of common stock	0	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0	0
Debt financing costs	0	0	0
Purchase of non-controlling interest			(66)
Changes in intercompany balances	(418)	(433)	(238)
Contribution from Parent	632	515	368
Net cash from financing activities	211	79	41
Effect of currency translation on cash	0	0	0
Net change in cash and cash equivalents	(8)	7	5
Cash and cash equivalents at beginning of period	12	5	0
Cash and cash equivalents at end of period	4	12	5
Non-Guarantor Subsidiaries [Member]
Condensed Supplemental Consolidated Statements of Cash Flows [Abstract]
Cash flow from operating activities	220	200	188
Cash Flow from Investing Activities [Abstract]
Additions to property, plant and equipment	(90)	(41)	(36)
Proceeds from sale of assets	0	0	0
(Contributions) distributions to/from subsidiaries	0	0	0
Intercompany advances (repayments)	0	0	0
Acquisition of business, net of cash acquired	(70)	0	(1,915)
Other investing activities, net		0	0
Net cash from investing activities	(160)	(41)	(1,951)
Cash Flow from Financing Activities [Abstract]
Proceeds from long-term borrowings	0	0	0
Repayment of long-term borrowings	(1)	(1)	(51)
Proceeds from issuance of common stock	0	0	0
Repurchase of common stock	0
Payment of tax receivable agreement	0	0	0
Debt financing costs	0	0	0
Purchase of non-controlling interest			(12)
Changes in intercompany balances	(157)	(106)	85
Contribution from Parent	73	0	1,892
Net cash from financing activities	(85)	(107)	1,914
Effect of currency translation on cash	(7)	8	0
Net change in cash and cash equivalents	(32)	60	151
Cash and cash equivalents at beginning of period	276	216	65
Cash and cash equivalents at end of period	$ 244	$ 276	$ 216

Quarterly Financial Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Sep. 29, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2017	Jul. 01, 2017	Apr. 01, 2017	Dec. 31, 2016	Sep. 29, 2018	Sep. 30, 2017	Oct. 01, 2016
Quarterly Financial Data (Unaudited) [Abstract]
Net sales	$ 2,054	$ 2,072	$ 1,967	$ 1,776	$ 1,881	$ 1,906	$ 1,806	$ 1,502	$ 7,869	$ 7,095	$ 6,489
Cost of goods sold	1,705	1,690	1,596	1,447	1,514	1,518	1,453	1,206	6,438	5,691	5,202
Gross profit	349	382	371	329	367	388	353	296
Net income	$ 133	$ 110	$ 90	$ 163	$ 110	$ 107	$ 72	$ 51	$ 496	$ 340	$ 236
Net Income per Share [Abstract]
Basic (in dollars per share)	$ 1.01	$ 0.84	$ 0.69	$ 1.24	$ 0.84	$ 0.82	$ 0.56	$ 0.42	$ 3.77	$ 2.66	$ 1.95
Diluted (in dollars per share)	$ 0.99	$ 0.81	$ 0.66	$ 1.20	$ 0.81	$ 0.79	$ 0.54	$ 0.40	$ 3.67	$ 2.56	$ 1.89

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Basis of Presentation and Summary of Significant Accounting Policies, Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 162	$ 129

Basis of Presentation and Summary of Significant Accounting Policies, Deferred Financing Fees (Details) $ in Millions	Sep. 29, 2018 USD ($)
Deferred Financing Fees [Abstract]
Debt issuance and deferred financing costs	$ 43

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Sep. 29, 2018	Sep. 30, 2017
Stockholders' equity:
Common stock, shares issued (in shares)	131.4	130.9

Basis of Presentation and Summary of Significant Accounting Policies, Accrued Rebates (Details) - USD ($) $ in Millions	Sep. 29, 2018	Sep. 30, 2017
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Accrual for customer rebates	$ 58	$ 58